review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Michael Karin | Q1458081 |
Florian Greten | Q17321656 | ||
P2860 | cites work | The Hallmarks of Cancer | Q221226 |
A proinflammatory cytokine inhibits p53 tumor suppressor activity | Q22010796 | ||
IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis | Q24320080 | ||
Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses | Q24562026 | ||
Inflammation and cancer | Q24649640 | ||
Inflammation and cancer: back to Virchow? | Q28036756 | ||
Interleukin-1 polymorphisms associated with increased risk of gastric cancer | Q28140456 | ||
Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis | Q28166328 | ||
A prospective study of aspirin use and the risk of pancreatic cancer in women | Q28166674 | ||
Aspirin for cancer chemoprevention: still a headache? | Q28167300 | ||
Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study | Q28167302 | ||
Regulation of cutaneous malignancy by gammadelta T cells | Q28188439 | ||
Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma | Q28196753 | ||
NF-kappaB regulation in the immune system | Q28205043 | ||
COX-2 inhibition and colorectal cancer | Q28208652 | ||
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial | Q28217835 | ||
Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases | Q28239642 | ||
IL-1 is required for tumor invasiveness and angiogenesis | Q28594748 | ||
Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases | Q29547555 | ||
Signaling to NF-kappaB | Q29547844 | ||
Missing pieces in the NF-kappaB puzzle | Q29547864 | ||
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 | ||
The two NF-kappaB activation pathways and their role in innate and adaptive immunity | Q29614355 | ||
NF-kappaB functions as a tumour promoter in inflammation-associated cancer | Q29614598 | ||
IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer | Q29614599 | ||
NF-kappaB in cancer: from innocent bystander to major culprit | Q29614603 | ||
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis | Q29616121 | ||
The immunobiology of cancer immunosurveillance and immunoediting | Q29616246 | ||
Smoldering and polarized inflammation in the initiation and promotion of malignant disease | Q29618034 | ||
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability | Q29618122 | ||
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention | Q29620087 | ||
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity | Q29620119 | ||
Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. | Q31775425 | ||
Possible role of ovarian epithelial inflammation in ovarian cancer | Q33724007 | ||
Liver regeneration | Q33870218 | ||
Infections as a major preventable cause of human cancer | Q33916455 | ||
Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. | Q33967257 | ||
Tumor angiogenesis, macrophages, and cytokines | Q34009001 | ||
Cytokines in cancer pathogenesis and cancer therapy | Q34288123 | ||
Addicted to death: invasive cancer and the immune response to unscheduled cell death | Q34378991 | ||
Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression | Q34467878 | ||
Tumor necrosis factor or tumor promoting factor? | Q34568701 | ||
von Hippel-Lindau protein-mediated repression of tumor necrosis factor alpha translation revealed through use of cDNA arrays | Q34784862 | ||
Nature's TRAIL--on a path to cancer immunotherapy | Q35046572 | ||
Does the immune system see tumors as foreign or self? | Q35077428 | ||
The IKK NF-kappa B system: a treasure trove for drug development | Q35621375 | ||
Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. | Q35806727 | ||
Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. | Q35913517 | ||
Inflammation as a tumor promoter in cancer induction | Q35920466 | ||
The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis | Q36368249 | ||
The distinct contributions of murine T cell receptor (TCR)gammadelta+ and TCRalphabeta+ T cells to different stages of chemically induced skin cancer | Q36371644 | ||
Regulation of the chemokine receptor CXCR4 by hypoxia | Q36371842 | ||
Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype | Q36375875 | ||
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice | Q36497106 | ||
Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition | Q37415678 | ||
NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK. | Q40431585 | ||
Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression | Q40513415 | ||
Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells | Q41088207 | ||
Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway | Q42523288 | ||
Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells | Q42947524 | ||
Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases | Q43612862 | ||
Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development | Q44683813 | ||
NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. | Q45982548 | ||
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent | Q46068963 | ||
IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis | Q46576855 | ||
CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. | Q51463026 | ||
Chemopreventive agents induce suppression of nuclear factor-kappaB leading to chemosensitization. | Q53384485 | ||
TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. | Q54697386 | ||
The epidemiology of gastric cancer | Q57586419 | ||
Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer | Q58212139 | ||
IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation | Q59054264 | ||
Sequence Variants in Toll-Like Receptor Gene Cluster (TLR6-TLR1-TLR10) and Prostate Cancer Risk | Q61853345 | ||
c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin | Q73291709 | ||
Increased mast cell density in invasive melanoma | Q74330260 | ||
Inhibition of Rel/Nuclear Factor-kappaB signaling in skin results in defective DNA damage-induced cell cycle arrest and Ha-ras- and p53-independent tumor development | Q74463183 | ||
Inflammation and necrosis promote tumour growth | Q80402773 | ||
Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A | Q80501633 | ||
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis | Q80998934 | ||
Gastric cancer originating from bone marrow-derived cells | Q81067451 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | NF-κB | Q411114 |
inflammation | Q101991 | ||
P304 | page(s) | 749-759 | |
P577 | publication date | 2005-10-01 | |
P1433 | published in | Nature Reviews Immunology | Q43355 |
P1476 | title | NF-kappaB: linking inflammation and immunity to cancer development and progression | |
P478 | volume | 5 |
Q36681789 | (E)-2,4-bis(p-hydroxyphenyl)-2-butenal has an antiproliferative effect on NSCLC cells induced by p38 MAPK-mediated suppression of NF-κB and up-regulation of TNFRSF10B (DR5). |
Q33997214 | 17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition |
Q42217850 | 2011: the immune hallmarks of cancer |
Q89834779 | 2α-Hydroxyeudesma-4,11(13)-Dien-8β,12-Olide Isolated from Inula britannica Induces Apoptosis in Diffuse Large B-cell Lymphoma Cells |
Q35533521 | 3,4-Dihydroxy-benzohydroxamic acid (Didox) suppresses pro-inflammatory profiles and oxidative stress in TLR4-activated RAW264.7 murine macrophages |
Q46254222 | 8-Oxoguanine DNA glycosylase 1: Beyond repair of the oxidatively modified base lesions. |
Q33399068 | 9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways |
Q53295110 | A Role for Lymphotoxin in Primary Sjögren’s Disease |
Q47262769 | A common variant in the precursor miR-146a sequence does not predispose to cholangiocarcinoma in a large European cohort. |
Q35108769 | A compensatory role of NF-κB to p53 in response to 5-FU-based chemotherapy for gastric cancer cell lines |
Q34625152 | A cytokine-mediated link between innate immunity, inflammation, and cancer |
Q39928939 | A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling |
Q36962761 | A double-edged sword: how oncogenes and tumor suppressor genes can contribute to chromosomal instability |
Q35015686 | A dual role for the immune response in a mouse model of inflammation-associated lung cancer |
Q37359026 | A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension |
Q42039947 | A genome-wide RNA interference screen identifies caspase 4 as a factor required for tumor necrosis factor alpha signaling. |
Q90069095 | A genome-wide screen for human salicylic acid (SA)-binding proteins reveals targets through which SA may influence development of various diseases |
Q37976467 | A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targets |
Q24630221 | A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses |
Q24602478 | A miR-19 regulon that controls NF-κB signaling |
Q28393278 | A multi-targeted approach to suppress tumor-promoting inflammation |
Q44634969 | A new flavan-3-ol and the anti-inflammatory effect of flavonoids from the fruit peels of Wisteria floribunda. |
Q36906449 | A new look at T cell receptor signaling to nuclear factor-κB |
Q37490772 | A new multicolor bioluminescence imaging platform to investigate NF-κB activity and apoptosis in human breast cancer cells |
Q37419942 | A new role for NFκB in immunosurveillance and its implications for cancer immunotherapy |
Q41295458 | A new role for microRNAs, as ligands of Toll-like receptors |
Q44923694 | A novel mechanism of tissue inhibitor of metalloproteinases-1 activation by interleukin-1 in primary human astrocytes |
Q40094086 | A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells |
Q48962375 | A novel series of IKKβ inhibitors part I: Initial SAR studies of a HTS hit |
Q83979425 | A phase 2 study of irinotecan, cisplatin, and simvastatin for untreated extensive-disease small cell lung cancer |
Q37195823 | A pilot study on acute inflammation and cancer: a new balance between IFN-gamma and TGF-beta in melanoma |
Q39078279 | A positive feedback loop between STAT3 and cyclooxygenase-2 gene may contribute to Helicobacter pylori-associated human gastric tumorigenesis |
Q58543600 | A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas |
Q35617840 | A quantitative model of thermal injury-induced acute inflammation |
Q41892002 | A redox economical synthesis of bioactive 6,12-guaianolides. |
Q34135803 | A review of the application of inflammatory biomarkers in epidemiologic cancer research |
Q38093040 | A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2011. |
Q91716396 | A typical carcinoid of the lung - a case report with pathological correlation and propagation of the cancer stem cell line BKZ1 with synaptophysin expression |
Q36251372 | A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression |
Q38163423 | A20-mediated negative regulation of canonical NF-κB signaling pathway |
Q37325315 | A20: central gatekeeper in inflammation and immunity |
Q24336707 | ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB |
Q39810390 | ABIN-1 negatively regulates NF-kappaB by inhibiting processing of the p105 precursor |
Q58790965 | AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients |
Q92299091 | AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging |
Q35963779 | ARTD1 Suppresses Interleukin 6 Expression by Repressing MLL1-Dependent Histone H3 Trimethylation. |
Q37589257 | Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer |
Q64280054 | Aberrant expression and high-frequency mutations of in nonmelanoma skin cancer |
Q37590127 | Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB. |
Q33719713 | Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks |
Q47119773 | Acquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF-κB pathway in EGFR-mutant NSCLC. |
Q41839580 | Acquisition of Genetic Aberrations by Activation-Induced Cytidine Deaminase (AID) during Inflammation-Associated Carcinogenesis |
Q34111440 | Activated macrophages in the tumour microenvironment-dancing to the tune of TLR and NF-kappaB |
Q53070583 | Activation of AhR with nuclear IKKα regulates cancer stem-like properties in the occurrence of radioresistance. |
Q45266303 | Activation of nuclear factor-kappa B and cell adhesion molecule mRNA expression in duodenal mucosa of dogs with lymphocytic-plasmacytic enteritis |
Q90442533 | Activation of the Toll‑like receptor 2 signaling pathway inhibits the proliferation of HCC cells in vitro |
Q28392256 | Activation of the glutaredoxin-1 gene by nuclear factor κB enhances signaling |
Q46729038 | Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma |
Q42512219 | Acute inflammation regulates neuroregeneration through the NF-κB pathway in olfactory epithelium |
Q33885950 | Adaptations to climate-mediated selective pressures in humans |
Q37685442 | Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells |
Q37036746 | Advances in targeting IKK and IKK-related kinases for cancer therapy |
Q37462069 | Aging and inflammation: etiological culprits of cancer |
Q35188247 | Aging-associated changes in hematopoiesis and leukemogenesis: what's the connection? |
Q37711310 | Alcohol, nutrition and liver cancer: role of Toll-like receptor signaling |
Q38966604 | Allantopyrone A, an α-pyrone metabolite from an endophytic fungus, inhibits the tumor necrosis factor α-induced nuclear factor κB signaling pathway |
Q90632706 | Alpha-Glucosidase Inhibitor Voglibose Suppresses Azoxymethane-Induced Colonic Preneoplastic Lesions in Diabetic and Obese Mice |
Q46218163 | Alpha-lipoic acid improves acetic acid-induced gastric ulcer healing in rats |
Q33889390 | Alpha-tomatine induces apoptosis and inhibits nuclear factor-kappa B activation on human prostatic adenocarcinoma PC-3 cells |
Q38160777 | Alterations in macrophages and monocytes from tumor-bearing mice: evidence of local and systemic immune impairment. |
Q37041538 | Altered TAB1:I kappaB kinase interaction promotes transforming growth factor beta-mediated nuclear factor-kappaB activation during breast cancer progression |
Q33602290 | Altered expression of histone deacetylases, inflammatory cytokines and contractile-associated factors in uterine myometrium of Long Evans rats gestationally exposed to benzo[a]pyrene |
Q36809767 | Altered macrophage differentiation and immune dysfunction in tumor development |
Q24294345 | An Atypical E3 Ligase Zinc Finger Protein 91 Stabilizes and Activates NF-κB-inducing Kinase via Lys63-linked Ubiquitination |
Q36543809 | An evolutionarily conserved innate immunity protein interaction network |
Q64068156 | An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set |
Q36332304 | An in vitro study showing the three-dimensional microenvironment influence over the behavior of head and neck squamous cell carcinoma |
Q47151590 | An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era. |
Q36338202 | An integrated method for the identification of novel genes related to oral cancer |
Q33528269 | An integrative modular approach to systematically predict gene-phenotype associations |
Q38038498 | An overview of transcriptional regulation in response to toxicological insult. |
Q90485486 | Annotation and cluster analysis of long noncoding RNA linked to male sex and estrogen in cancers |
Q64125847 | Anti-IL-6 receptor mAb eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T-cell responses |
Q33744128 | Anti-Inflammatory Activity and Structure-Activity Relationships of Brominated Indoles from a Marine Mollusc. |
Q41125099 | Anti-Inflammatory Effects of Capsaicin and Piperine on Helicobacter pylori-Induced Chronic Gastritis in Mongolian Gerbils. |
Q35821696 | Anti-Inflammatory Effects of Novel Standardized Solid Lipid Curcumin Formulations |
Q47946921 | Anti-Inflammatory Effects of Schisandrin B on LPS-Stimulated BV2 Microglia via Activating PPAR-γ. |
Q39566599 | Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-κB. |
Q53283288 | Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-κB signalling in lymphoma-bearing mice. |
Q50708999 | Anti-fibrotic effects of tetrandrine on bile-duct ligated rats. |
Q47330928 | Anti-inflammatory Effects of Rosmarinic Acid in Lipopolysaccharide-Induced Mastitis in Mice. |
Q37679431 | Anti-inflammatory activity of compounds isolated from Astragalus sinicus L. in cytokine-induced keratinocytes and skin |
Q47160621 | Anti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis |
Q51382039 | Anti-rheumatic drug iguratimod (T-614) alleviates cancer-induced bone destruction via down-regulating interleukin-6 production in a nuclear factor-κB-dependent manner. |
Q89407909 | Anti-tumor activity of wogonin, an extract from Scutellaria baicalensis, through regulating different signaling pathways |
Q47133210 | Anticancer activity of Astragalus polysaccharide in human non-small cell lung cancer cells |
Q58572122 | Anticancer effects of curcumin on nude mice bearing lung cancer A549 cell subsets SP and NSP cells |
Q48101367 | Antifibrotic effects of D-limonene (5(1-methyl-4-[1-methylethenyl]) cyclohexane) in CCl4 induced liver toxicity in Wistar rats. |
Q50901671 | Antioxidant activities of curcumin in allergic rhinitis. |
Q36945706 | Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy? |
Q49097159 | Antisense oligonucleotides against TNFR1 prevent toxicity of TNF/IFNγ treatment in mouse tumor models |
Q39399212 | Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-κB pathway. |
Q48514273 | Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma. |
Q34309920 | Apc-Mutant Kyoto Apc Delta (KAD) Rats Are Susceptible to 4-NQO-Induced Tongue Carcinogenesis |
Q55345439 | Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier in Vitro. |
Q35910652 | ApoM Suppresses TNF-α-Induced Expression of ICAM-1 and VCAM-1 Through Inhibiting the Activity of NF-κB |
Q61835940 | Apoptosis Inhibition Can Be Threatening in Aβ-Induced Neuroinflammation, Through Promoting Cell Proliferation |
Q33748016 | Apoptosis induction by 13-acetoxyrolandrolide through the mitochondrial intrinsic pathway. |
Q36815310 | Apoptosis pathways as promising targets for skin cancer therapy |
Q47354821 | Apoptotic Cells Induced Signaling for Immune Homeostasis in Macrophages and Dendritic Cells |
Q42956874 | Apple, cherry, and blackcurrant increases nuclear factor kappa B activation in liver of transgenic mice. |
Q38557650 | Applying nanomedicine in maladaptive inflammation and angiogenesis |
Q38759245 | Arctigenin Confers Neuroprotection Against Mechanical Trauma Injury in Human Neuroblastoma SH-SY5Y Cells by Regulating miRNA-16 and miRNA-199a Expression to Alleviate Inflammation |
Q26830307 | Are hematopoietic stem cells involved in hepatocarcinogenesis? |
Q39109776 | Arsenic trioxide suppressed mantle cell lymphoma by downregulation of cyclin D1. |
Q38725091 | Artemisinin inhibits inflammatory response via regulating NF-κB and MAPK signaling pathways |
Q90009344 | Asperuloside and Asperulosidic Acid Exert an Anti-Inflammatory Effect via Suppression of the NF-κB and MAPK Signaling Pathways in LPS-Induced RAW 264.7 Macrophages |
Q43535631 | Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis |
Q49721789 | Association between lysyl oxidase and fibrotic focus in relation with inflammation in breast cancer |
Q51115447 | Association of MAP4K4 gene single nucleotide polymorphism with mastitis and milk traits in Chinese Holstein cattle. |
Q34176403 | Association of Mycoplasma hominis infection with prostate cancer |
Q86494702 | Association of interleukin-10, tumor necrosis factor-α and transforming growth factor-β gene polymorphisms with the outcome of diffuse large B-cell lymphomas |
Q80732292 | Association of progressive structural changes in the bronchial epithelium with subepithelial fibrous remodeling: a potential role for hypoxia |
Q84818875 | Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2 |
Q33660226 | Astaxanthin protects astrocytes against trauma-induced apoptosis through inhibition of NKCC1 expression via the NF-κB signaling pathway |
Q58694758 | Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling |
Q54208087 | Astragalus membranaceus Extract Attenuates Inflammation and Oxidative Stress in Intestinal Epithelial Cells via NF-κB Activation and Nrf2 Response. |
Q33766869 | Attenuation of Carcinogenesis and the Mechanism Underlying by the Influence of Indole-3-carbinol and Its Metabolite 3,3'-Diindolylmethane: A Therapeutic Marvel |
Q55260178 | Augmented O-GlcNAcylation alleviates inflammation-mediated colon carcinogenesis via suppression of acute inflammation. |
Q35085362 | Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model |
Q38341491 | Aurora-A Contributes to Radioresistance by Increasing NF-κB DNA Binding |
Q37696994 | Avian leukosis virus subgroup J induces VEGF expression via NF-κB/PI3K-dependent IL-6 production |
Q42176053 | Awareness and current knowledge of breast cancer. |
Q34059352 | B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression |
Q64116739 | BAM15 attenuates transportation-induced apoptosis in iPS-differentiated retinal tissue |
Q52679779 | BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment. |
Q34972203 | BI 5700, a Selective Chemical Inhibitor of IκB Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression |
Q37696175 | Babao Dan attenuates hepatic fibrosis by inhibiting hepatic stellate cells activation and proliferation via TLR4 signaling pathway. |
Q33737879 | Bacterial oncogenesis in the colon |
Q34158284 | Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells |
Q37707525 | Berberine affects osteosarcoma via downregulating the caspase-1/IL-1β signaling axis |
Q38696079 | Berberine inhibits colitis-associated tumorigenesis via suppressing inflammatory responses and the consequent EGFR signaling-involved tumor cell growth |
Q34685488 | Berteroin present in cruciferous vegetables exerts potent anti-inflammatory properties in murine macrophages and mouse skin |
Q29616793 | Beta-arrestins and cell signaling |
Q36625618 | Betulinic acid enhances TGF-β signaling by altering TGF-β receptors partitioning between lipid-raft/caveolae and non-caveolae membrane microdomains in mink lung epithelial cells |
Q89029472 | Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy |
Q28743513 | Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers |
Q36133116 | Bicyclic Cyclohexenones as Inhibitors of NF-κB Signaling |
Q39202139 | Bile acids affect the growth of human cholangiocarcinoma via NF-kB pathway |
Q35004559 | Binding of NF-κB to nucleosomes: effect of translational positioning, nucleosome remodeling and linker histone H1. |
Q33684696 | Bioactive sesquiterpene lactones and other compounds isolated from Vernonia cinerea. |
Q46611038 | Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma |
Q38121858 | Biochemical and molecular mechanisms for the association between obesity, chronic inflammation, and breast cancer |
Q37201984 | Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple myeloma: therapeutic implications |
Q104495231 | Biological and physical approaches on the role of piplartine (piperlongumine) in cancer |
Q48640596 | Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-κB Pathway in Endometrial Cancer |
Q39986163 | Bioluminescence imaging of hollow fibers in living animals: its application in monitoring molecular pathways |
Q46374579 | Blockade of tumor necrosis factor-induced Bid cleavage by caspase-resistant Rb. |
Q39652497 | Blocking NF-κB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death |
Q35983857 | Blocking NF-κB: an inflammatory issue |
Q35039902 | Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease |
Q37291635 | Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells |
Q38343228 | Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress |
Q51118615 | Boswellia serrata resin extract alleviates azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colon tumorigenesis. |
Q24293271 | Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA |
Q40230617 | Brd4 modulates the innate immune response through Mnk2-eIF4E pathway-dependent translational control of IκBα. |
Q24304385 | Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis |
Q39066460 | Breast tumor cell TACE-shed MCSF promotes pro-angiogenic macrophages through NF-κB signaling |
Q35925490 | Brewers' rice modulates oxidative stress in azoxymethane-mediated colon carcinogenesis in rats. |
Q64099847 | Burm. Methanol Extract Attenuates LPS-Induced Inflammatory Activities in Macrophage-Like RAW264.7 Cells |
Q34304775 | C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy). |
Q38877112 | C/EBPβ Mediates TNF-α-Induced Cancer Cell Migration by Inducing MMP Expression Dependent on p38 MAPK. |
Q35541785 | CAPC negatively regulates NF-κB activation and suppresses tumor growth and metastasis |
Q64279279 | CCL18 promotes the metastasis of squamous cell carcinoma of the head and neck through MTDH-NF-κB signalling pathway |
Q38829381 | CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-κB signaling pathway in hepatocellular carcinoma |
Q37249670 | CCR2 promotes hepatic fibrosis in mice |
Q36751581 | CCR7 mediates inflammation-associated tumor progression |
Q39437258 | CD73 represses pro-inflammatory responses in human endothelial cells |
Q34533022 | CDA-2, a urinary preparation, inhibits lung cancer development through the suppression of NF-kappaB activation in myeloid cell |
Q91618169 | CHUK/IKK-α loss in lung epithelial cells enhances NSCLC growth associated with HIF up-regulation |
Q36922782 | CUEDC2: an emerging key player in inflammation and tumorigenesis |
Q43981767 | CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-κB signaling. |
Q26765342 | Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies |
Q36587800 | Cancer and diet: How are they related? |
Q33608038 | Cancer biology in diabetes |
Q93116749 | Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway |
Q37153407 | Cancer risk in immune-mediated inflammatory diseases (IMID). |
Q33649230 | Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting |
Q64079366 | Cancer testis antigen 55 deficiency attenuates colitis-associated colorectal cancer by inhibiting NF-κB signaling |
Q38728887 | Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-κB activation |
Q39519626 | Candida virulence and ethanol-derived acetaldehyde production in oral cancer and non-cancer subjects |
Q36358540 | Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma |
Q38976898 | Carbon disulfide. Just toxic or also bioregulatory and/or therapeutic? |
Q50034271 | Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness. |
Q99201955 | Carcinogenesis: Failure of resolution of inflammation? |
Q36921618 | Caspase-9b Interacts Directly with cIAP1 to Drive Agonist-Independent Activation of NF-κB and Lung Tumorigenesis |
Q92064508 | Cause and effect of microenvironmental acidosis on bone metastases |
Q38853856 | Cecropin B Represses CYP3A29 Expression through Activation of the TLR2/4-NF-κB/PXR Signaling Pathway |
Q41016182 | Celastrol inhibits migration and invasion through blocking the NF-κB pathway in ovarian cancer cells |
Q41953684 | Cell Autonomous and Non-Autonomous Functions of IKKβ and NF-κB during the Pathogenesis of Gastrointestinal Tumors |
Q36824518 | Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications |
Q26800103 | Cell-type specific penetrating peptides: therapeutic promises and challenges |
Q37959331 | Cellular and molecular mechanisms of autoimmune disease |
Q37802043 | Cellular metabolic stress: considering how cells respond to nutrient excess. |
Q24623979 | Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist |
Q41142815 | Ceramide synthase-4 orchestrates the cell proliferation and tumor growth of liver cancer in vitro and in vivo through the nuclear factor-κB signaling pathway |
Q88633612 | Cereblon suppresses the lipopolysaccharide-induced inflammatory response by promoting the ubiquitination and degradation of c-Jun |
Q58696034 | Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study |
Q38646941 | Characterization and assessment of potential microRNAs involved in phosphate-induced aortic calcification. |
Q40264437 | Characterization of mechanisms involved in secretion of active heparanase |
Q47634278 | Chelidonine inhibits TNF-α-induced inflammation by suppressing the NF-κB pathways in HCT116 cells. |
Q37615916 | Chemical biology of inflammatory cytokine signaling |
Q28822335 | Chemical metabolic inhibitors for the treatment of blood-borne cancers |
Q35728558 | Chemokine receptor 7 (CCR7) gene expression is regulated by NF-κB and activator protein 1 (AP1) in metastatic squamous cell carcinoma of head and neck (SCCHN). |
Q36752040 | Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention? |
Q46663854 | Chemoprevention by white currant is mediated by the reduction of nuclear beta-catenin and NF-kappaB levels in Min mice adenomas |
Q37728618 | Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling |
Q35836432 | Chemopreventive effect of chalcone derivative, L2H17, in colon cancer development |
Q53315978 | Chemopreventive effects of the standardized extract (DA-9601) of Artemisia asiatica on azoxymethane-initiated and dextran sulfate sodium-promoted mouse colon carcinogenesis. |
Q36350221 | Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA |
Q35624238 | Chemotherapeutic properties of phospho-nonsteroidal anti-inflammatory drugs, a new class of anticancer compounds |
Q42750382 | Chitinase-like proteins are autoantigens in a model of inflammation-promoted incipient neoplasia |
Q37859424 | Chlamydial CT441 is a PDZ domain-containing tail-specific protease that interferes with the NF-kappaB pathway of immune response |
Q38673438 | Chromosomal instability triggers cell death via local signalling through the innate immune receptor Toll |
Q46489977 | Chronic Inflammation in Skin Malignancies |
Q42590248 | Chronic NF-kappaB activation delays RasV12-induced premature senescence of human fibroblasts by suppressing the DNA damage checkpoint response. |
Q99712023 | Chronic Stress Promotes Cancer Development |
Q34079481 | Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism |
Q91936590 | Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles |
Q48101725 | Chronic urinary tract infection and bladder carcinoma risk: a meta-analysis of case-control and cohort studies. |
Q34222534 | Circadian disruption, Per3, and human cytokine secretion |
Q37354561 | Circulating C-reactive protein and colorectal cancer risk: a report from the Shanghai Men's Health Study |
Q35918276 | Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer |
Q36536034 | Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients |
Q41604995 | Circulating tumor cell interactions with macrophages: implications for biology and treatment |
Q53651858 | Circulating tumor necrosis factor-α and YKL-40 level is associated with remission status following salvage therapy in relapsed non-Hodgkin lymphoma. |
Q40205251 | Clathrin complexes with the inhibitor kappa B kinase signalosome: imaging the interactome |
Q50916755 | Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens. |
Q35478306 | Clinical response to Auron Misheil Therapy in a man with advanced multifocal hepatocellular carcinoma: A case report |
Q42003261 | Clock gene Per2 as a controller of liver carcinogenesis |
Q37728405 | Cloning and characterization of DULP, a novel ubiquitin-like molecule from human dendritic cells |
Q39038239 | Co-culture with NK-92MI cells enhanced the anti-cancer effect of bee venom on NSCLC cells by inactivation of NF-κB. |
Q41143599 | Co-expression of β-arrestin1 and NF-кB is associated with cancer progression and poor prognosis in lung adenocarcinoma |
Q38199426 | Coffee and cancer risk, epidemiological evidence, and molecular mechanisms |
Q50561428 | Coffee, broccoli and spices are strong inducers of electrophile response element‐dependent transcription in vitro and in vivo – Studies in electrophile response element transgenic mice |
Q35247738 | Color-coded imaging of splenocyte-pancreatic cancer cell interactions in the tumor microenvironment |
Q42716078 | Colorectal carcinoma masked by systemic inflammatory response syndrome: A case report |
Q52960400 | Combination therapy with human umbilical cord mesenchymal stem cells and angiotensin-converting enzyme 2 is superior for the treatment of acute lung ischemia-reperfusion injury in rats. |
Q37906730 | Combinatorial strategies employing nutraceuticals for cancer development |
Q39651374 | Combined activity of oridonin and wogonin in advanced-stage ovarian cancer cells: sensitivity of ovarian cancer cells to phyto-active chemicals |
Q36480910 | Combined deletion of cathepsin protease family members reveals compensatory mechanisms in cancer |
Q39251309 | Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer |
Q42204382 | Combined experimental and computational analysis of DNA damage signaling reveals context-dependent roles for Erk in apoptosis and G1/S arrest after genotoxic stress |
Q37169890 | Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive Aspergillosis |
Q40105919 | Common effector processing mediates cell-specific responses to stimuli |
Q53176277 | Comparative Effects of Curcumin and Tetrahydrocurcumin on Dextran Sulfate Sodium-induced Colitis and Inflammatory Signaling in Mice. |
Q58063928 | Comparative expressed sequence hybridization studies of t(11;18)(q21;q21)-positive and -negative gastric MALT lymphomas reveal both unique and overlapping gene programs |
Q33779529 | Comparative genomics RNAi screen identifies Eftud2 as a novel regulator of innate immunity |
Q37290391 | Comprehensive evaluation of a novel nuclear factor-kappaB inhibitor, quinoclamine, by transcriptomic analysis |
Q35018212 | Computational modeling of mammalian signaling networks |
Q36388394 | Concise review: Cancer stem cells and minimal residual disease |
Q42747071 | Concurrent sulforaphane and eugenol induces differential effects on human cervical cancer cells |
Q33968131 | Conditional ablation of Ikkb inhibits melanoma tumor development in mice |
Q36336969 | Conditional deletion of Stat3 in mammary epithelium impairs the acute phase response and modulates immune cell numbers during post-lactational regression |
Q41778161 | Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo |
Q38985389 | Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151. |
Q34708248 | Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers |
Q28512993 | Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways |
Q34509419 | Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. |
Q24307551 | Copine-I represses NF-kappaB transcription by endoproteolysis of p65 |
Q36493235 | Correlation between mimecan expression and coronary artery stenosis in patients with coronary heart disease |
Q35156115 | Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinoma |
Q39547330 | Counteracting effect of TRPC1-associated Ca2+ influx on TNF-α-induced COX-2-dependent prostaglandin E2 production in human colonic myofibroblasts |
Q48209599 | Critical cholangiocarcinogenesis control by cryptochrome clock genes |
Q92926171 | Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment |
Q36691086 | Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. |
Q37736505 | Crosstalk between signals initiated from TLR4 and cell surface BAFF results in synergistic induction of proinflammatory mediators in THP-1 cells |
Q42586119 | Crotamine stimulates phagocytic activity by inducing nitric oxide and TNF-α via p38 and NFκ-B signaling in RAW 264.7 macrophages |
Q34328887 | Cryptopleurine targets NF-κB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis |
Q54386411 | Cucurbitacin B suppresses the transactivation activity of RelA/p65. |
Q39202485 | Cucurbitacin E exhibits anti-inflammatory effect in RAW 264.7 cells via suppression of NF-κB nuclear translocation. |
Q35108012 | Cucurbitacin IIb exhibits anti-inflammatory activity through modulating multiple cellular behaviors of mouse lymphocytes |
Q36012401 | Curcumin attenuates gastric cancer induced by N-methyl-N-nitrosourea and saturated sodium chloride in rats |
Q38636412 | Curcumin prevents reperfusion injury following ischemic stroke in rats via inhibition of NF‑κB, ICAM-1, MMP-9 and caspase-3 expression |
Q28393316 | Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment |
Q28261784 | Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis |
Q35224208 | Cyclophilin A (CypA) interacts with NF-κB subunit, p65/RelA, and contributes to NF-κB activation signaling |
Q36960346 | Cyp1b1 exerts opposing effects on intestinal tumorigenesis via exogenous and endogenous substrates |
Q28308101 | Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer |
Q35626872 | Cytokine induction of tumor necrosis factor receptor 2 is mediated by STAT3 in colon cancer cells |
Q33358117 | Cytokine plasma levels: reliable predictors for radiation pneumonitis? |
Q34542117 | Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma |
Q53544015 | Cytosolic Hsp60 orchestrates the survival and inflammatory responses of vascular smooth muscle cells in injured aortic vessels. |
Q58784334 | D-ribose induces nephropathy through RAGE-dependent NF-κB inflammation |
Q37535386 | DAMPs and inflammatory processes: the role of redox in the different outcomes |
Q36296488 | DMA(V) in Drinking Water Activated NF-κB Signal Pathway and Increased TGF-β and IL-1β Expressions in Bladder Epithelial Cells of Rats |
Q39944664 | DNA methyltransferase 3B mutant in ICF syndrome interacts non-covalently with SUMO-1. |
Q36960228 | DYT-40, a novel synthetic 2-styryl-5-nitroimidazole derivative, blocks malignant glioblastoma growth and invasion by inhibiting AEG-1 and NF-κB signaling pathways |
Q28267996 | Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer |
Q53257548 | Death-associated protein kinase controls STAT3 activity in intestinal epithelial cells. |
Q26826876 | Dedifferentiation and reprogramming: origins of cancer stem cells |
Q28507762 | Deletion of Fanca or Fancd2 dysregulates Treg in mice |
Q39925925 | Delphinidin, a dietary anthocyanidin in pigmented fruits and vegetables: a new weapon to blunt prostate cancer growth |
Q38091116 | Dendritic cell tumor killing activity and its potential applications in cancer immunotherapy |
Q38952158 | Dendritic cell-mediated survival signals in Eμ-Myc B-cell lymphoma depend on the transcription factor C/EBPβ. |
Q34212591 | Deregulated inflammasome signaling in disease |
Q24648025 | Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer |
Q35742808 | Design, synthesis and biological evaluation of bivalent benzoxazolone and benzothiazolone ligands as potential anti-inflammatory/analgesic agents. |
Q40158562 | Detection and a possible link between parvovirus B19 and thyroid cancer. |
Q55113244 | Detection of a lipid peroxidation-induced DNA adduct across liver disease stages. |
Q38700300 | Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), an anticancer agent, exerts an anti-inflammatory effect in activated human mast cells |
Q36529779 | Dichotomies in cancer research: some suggestions for a new synthesis |
Q39937068 | Dichotomous metabolism of Enterococcus faecalis induced by haematin starvation modulates colonic gene expression |
Q33758929 | Diet components can suppress inflammation and reduce cancer risk |
Q36131792 | Dietary Glucosinolates Sulforaphane, Phenethyl Isothiocyanate, Indole-3-Carbinol/3,3'-Diindolylmethane: Anti-Oxidative Stress/Inflammation, Nrf2, Epigenetics/Epigenomics and In Vivo Cancer Chemopreventive Efficacy |
Q90387094 | Dietary Inflammatory Index and Site-Specific Cancer Risk: A Systematic Review and Dose-Response Meta-Analysis |
Q90193038 | Dietary Polyacetylenic Oxylipins Falcarinol and Falcarindiol Prevent Inflammation and Colorectal Neoplastic Transformation: A Mechanistic and Dose-Response Study in A Rat Model |
Q37370591 | Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. |
Q37095276 | Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study |
Q58793547 | Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention |
Q48236727 | Dietary polyacetylenes, falcarinol and falcarindiol, isolated from carrots prevents the formation of neoplastic lesions in the colon of azoxymethane-induced rats |
Q34241444 | Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature |
Q34766399 | Differential activation of NF-κB and nitric oxide in lymphocytes regulates in vitro and in vivo radiosensitivity |
Q33864180 | Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols |
Q21135494 | Differential expression of microRNAs in tumors from chronically inflamed or genetic (APC(Min/+)) models of colon cancer |
Q39653034 | Differential expression of mucins in Middle Eastern patients with colorectal cancer |
Q34750616 | Differential gene expression profiling of gastric intraepithelial neoplasia and early-stage adenocarcinoma |
Q90643299 | Differential impact of classical and non-canonical NF-κB pathway-related gene expression on the survival of breast cancer patients |
Q41965715 | Differential requirements for IKKalpha and IKKbeta in the differentiation of primary human osteoarthritic chondrocytes. |
Q39338015 | Dihydromyricetin suppresses TNF-α-induced NF-κB activation and target gene expression |
Q37855820 | Direct Rel/NF-κB inhibitors: structural basis for mechanism of action |
Q34255576 | Disruption of microtubules sensitizes the DNA damage-induced apoptosis through inhibiting nuclear factor κB (NF-κB) DNA-binding activity |
Q47138550 | Dissecting cellular senescence and SASP in Drosophila |
Q26783559 | Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer |
Q36464593 | Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy |
Q37890981 | Does absolute neutrophil count predict high tumor grade in African-American men with prostate cancer? |
Q34176503 | Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. |
Q39509449 | Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state |
Q38940255 | Down-regulation of testes-specific protease 50 induces apoptosis in human laryngocarcinoma HEp2 cells in a NF-κB-mediated pathway |
Q34542594 | Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity |
Q47146670 | Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer |
Q39119385 | Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells |
Q35964572 | Doxycycline Promotes Carcinogenesis & Metastasis via Chronic Inflammatory Pathway: An In Vivo Approach |
Q38017594 | Driving transcriptional regulators in melanoma metastasis |
Q91846149 | Dual TBK1/IKKɛ inhibitor amlexanox attenuates the severity of hepatotoxin-induced liver fibrosis and biliary fibrosis in mice |
Q33815901 | Dual effects of ouabain on the regulation of proliferation and apoptosis in human umbilical vein endothelial cells: involvement of Na(+)-K(+)-ATPase α-subunits and NF-κB. |
Q54309191 | Dynamic activation of the key pathways: linking colitis to colorectal cancer in a mouse model. |
Q33754562 | Dynamic, Large-Scale Profiling of Transcription Factor Activity from Live Cells in 3D Culture |
Q37274623 | Dysregulated molecular networks in head and neck carcinogenesis |
Q39794252 | Dysregulation of hepatocyte cell cycle and cell viability by hepatitis B virus |
Q27000278 | E-cadherin and gastric cancer: cause, consequence, and applications |
Q57369632 | E3 ubiquitin ligase Cblb regulates the acute inflammatory response underlying lung injury |
Q37589139 | EI24 regulates epithelial-to-mesenchymal transition and tumor progression by suppressing TRAF2-mediated NF-κB activity |
Q28397459 | Early life environment and developmental immunotoxicity in inflammatory dysfunction and disease |
Q41130171 | Ebselen abrogates TNFalpha induced pro-inflammatory response in glioblastoma. |
Q40010639 | Ectodomain shedding of TNF receptor 1 induced by protein synthesis inhibitors regulates TNF-alpha-mediated activation of NF-kappaB and caspase-8. |
Q94528302 | Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling |
Q33885430 | Effect of dietary supplementation of procyanidin on growth performance and immune response in pigs |
Q34735346 | Effect of hypoxic stress-activated Polo-like kinase 3 on corneal epithelial wound healing |
Q55439924 | Effect of the dietary polyacetylenes falcarinol and falcarindiol on the gut microbiota composition in a rat model of colorectal cancer. |
Q92799604 | Effects of Dietary Inclusion of Shrimp Paste on Growth Performance, Digestive Enzymes Activities, Antioxidant and Immunological Status and Intestinal Morphology of Hybrid Snakehead (Channa maculata ♀ × Channa argus ♂) |
Q34235551 | Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer |
Q35418145 | Effects of a Chinese Herbal Medicine, Guan-Jen-Huang (Aeginetia indica Linn.), on Renal Cancer Cell Growth and Metastasis |
Q43937010 | Effects of bovine lactoferrin on the immature porcine intestine. |
Q35147800 | Effects of calorie restriction and diet-induced obesity on murine colon carcinogenesis, growth and inflammatory factors, and microRNA expression |
Q52724794 | Effects of consumption of whole grape powder on basal NF-κB signaling and inflammatory cytokine secretion in a mouse model of inflammation. |
Q42037601 | Effects of high mobility group protein box 1 and toll like receptor 4 pathway on warts caused by human papillomavirus |
Q42459759 | Effects of temperature-humidity index and chromium supplementation on antioxidant capacity, heat shock protein 72, and cytokine responses of lactating cows |
Q39304368 | Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial |
Q45872155 | Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: First evidence in preclinical hepatocellular carcinoma |
Q60934134 | Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling |
Q26778011 | Eicosanoid pathway in colorectal cancer: Recent updates |
Q42314594 | Elevated AEG-1 expression in macrophages promotes hypopharyngeal cancer invasion through the STAT3-MMP-9 signaling pathway |
Q35828619 | Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-κB signaling |
Q37571441 | Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer |
Q58423073 | Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer |
Q38965233 | Embelin and Its Role in Chronic Diseases |
Q34149945 | Embryonic stem cells and mammary luminal progenitors directly sense and respond to microbial products. |
Q26824613 | Emerging role of Toll-like receptor 4 in hepatocellular carcinoma |
Q35172778 | Emerging strategies for the early detection and prevention of head and neck squamous cell cancer |
Q83402616 | Emerging therapies for multiple myeloma |
Q37229916 | Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer |
Q38781958 | Endostatin inhibits the growth and migration of 4T1 mouse breast cancer cells by skewing macrophage polarity toward the M1 phenotype |
Q42922612 | Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents |
Q36252549 | Engagement of Components of DNA-Break Repair Complex and NFκB in Hsp70A1A Transcription Upregulation by Heat Shock |
Q37684206 | Enhanced Anti-Cancer Effect of Snake Venom Activated NK Cells on Lung Cancer Cells by Inactivation of NF-κB |
Q37680172 | Enhanced myeloid differentiation factor 88 promotes tumor metastasis via induction of epithelial-mesenchymal transition in human hepatocellular carcinoma |
Q37118186 | Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines |
Q30436566 | Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes |
Q28388059 | Epigenetic changes induced by air toxics: formaldehyde exposure alters miRNA expression profiles in human lung cells |
Q97653022 | Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment |
Q59091394 | Epithelial NEMO links innate immunity to chronic intestinal inflammation |
Q45942630 | Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model. |
Q48146199 | Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review. |
Q34595133 | Epithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer |
Q35952706 | Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1 |
Q37672258 | Epithelium: the interplay between innate and Th2 immunity |
Q35921787 | ErbB receptor tyrosine kinase/NF-κB signaling controls mammosphere formation in human breast cancer |
Q24337661 | Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling |
Q36877702 | Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma |
Q35920666 | Estrogen Protects against Obesity-Induced Mammary Gland Inflammation in Mice |
Q33636941 | Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells |
Q35120661 | Ethanol extract of Poria cocos reduces the production of inflammatory mediators by suppressing the NF-kappaB signaling pathway in lipopolysaccharide-stimulated RAW 264.7 macrophages |
Q35806083 | Evaluating Nuclear Factor NF-κB Activation following Bone Trauma: A Pilot Study in a Wistar Rats Model |
Q38459602 | Evaluation of Prognostic Nutritional Index in Patients Undergoing Radical Surgery with Nonsmall Cell Lung Cancer |
Q64066027 | Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma |
Q35588508 | Evidence for induction of a tumor metastasis-receptive microenvironment for ovarian cancer cells in bone marrow and other organs as an unwanted and underestimated side effect of chemotherapy/radiotherapy |
Q39735786 | Expression and regulation mechanisms of Sonic Hedgehog in breast cancer |
Q34784913 | Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors |
Q33325701 | Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas |
Q40150411 | Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling |
Q39979306 | Expression of chemokines and chemokine receptors in human colon cancer |
Q99711837 | Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis |
Q35166851 | Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice |
Q38932298 | Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche |
Q35781475 | Extracellular vesicles derived from renal cancer stem cells induce a pro-tumorigenic phenotype in mesenchymal stromal cells. |
Q34853120 | Extract of Artemisia lavandulaefolia Inhibits In Vitro Angiogenesis in Human Umbilical Vein Endothelial Cells |
Q91830768 | Extract of Makgeolli suldeot downregulates NF-κB-mediated MMP-9 expression, thereby inhibiting invasive activity in a human breast cancer cell line, MDA-MB-231 |
Q24300387 | FER tyrosine kinase (FER) overexpression mediates resistance to quinacrine through EGF-dependent activation of NF-kappaB |
Q28586517 | Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response |
Q36901888 | Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy |
Q38721869 | Ferulic acid suppresses expression of tryptophan metabolic key enzyme indoleamine 2, 3-dioxygenase via NFκB and p38 MAPK in lipopolysaccharide-stimulated microglial cells |
Q51835187 | Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism. |
Q37452775 | Fish oil suppresses cell growth and metastatic potential by regulating PTEN and NF-κB signaling in colorectal cancer |
Q64938182 | Flavonoids: New Frontier for Immuno-Regulation and Breast Cancer Control. |
Q39570966 | Fluoxetine inhibits NF-κB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice |
Q42183550 | Forkhead transcription factor FOXO3a protein activates nuclear factor κB through B-cell lymphoma/leukemia 10 (BCL10) protein and promotes tumor cell survival in serum deprivation |
Q33665928 | Formation of 8-nitroguanine, a nitrative DNA lesion, in inflammation-related carcinogenesis and its significance |
Q34650781 | Frequent engagement of RelB activation is critical for cell survival in multiple myeloma |
Q59808913 | From Friend to Enemy: Dissecting the Functional Alteration of Immunoregulatory Components during Pancreatic Tumorigenesis |
Q39192491 | Fucosterol inhibits matrix metalloproteinase expression and promotes type-1 procollagen production in UVB-induced HaCaT cells |
Q27009399 | Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology |
Q47709908 | Functional Toll-like receptor 4 expressed in lactotrophs mediates LPS-induced proliferation in experimental pituitary hyperplasia |
Q35087443 | Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains |
Q37866715 | Functional regulation of HIF-1α under normoxia--is there more than post-translational regulation? |
Q39205404 | Functional roles of tumor necrosis factor-related apoptosis-inducing ligand-DR5 interaction in B16F10 cells by activating the nuclear factor-κB pathway to induce metastatic potential |
Q37730952 | Functions of nuclear factor kappaB in bone |
Q37293340 | G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer |
Q90011228 | GIT1 regulates angiogenic factor secretion in bone marrow mesenchymal stem cells via NF-κB/Notch signalling to promote angiogenesis |
Q52430611 | GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade. |
Q28388105 | Gadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascades |
Q38746805 | Galeterone and VNPT55 disrupt Mnk-eIF4E to inhibit prostate cancer cell migration and invasion |
Q64891812 | Gastric carcinogenesis. |
Q37559231 | Gastrokine 1 expression in the human gastric mucosa is closely associated with the degree of gastritis and DNA methylation |
Q29614596 | Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production |
Q45989122 | Gender-specific association of NFKBIA promoter polymorphisms with the risk of sporadic colorectal cancer. |
Q36652500 | Gene Expression Quantification of Toll like Receptors 2, 4 and Co-molecules in Human Glioblastoma Cell Line (U87-MG): Toward a New In vitro Model of Inflammation |
Q26801146 | Genetic Association Between NFKBIA -881A>G Polymorphism and Cancer Susceptibility |
Q88963822 | Genetic Modifiers of the Breast Tumor Microenvironment |
Q24311010 | Genetic aspects of inflammation and cancer |
Q36732083 | Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice |
Q36622888 | Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma |
Q33641328 | Genetic susceptibility to lymphoma |
Q35556219 | Genetic variation in inflammatory pathways is related to colorectal cancer survival |
Q56558872 | Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction |
Q54977208 | Glycogen synthase kinase-3β activity plays a key role in the antitumor effect of nafamostat mesilate in pancreatic cancer cells. |
Q24336114 | Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation |
Q34606453 | Glycyrrhizic acid suppresses the development of precancerous lesions via regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats |
Q42779829 | Graph-based identification of cancer signaling pathways from published gene expression signatures using PubLiME |
Q46750131 | Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model |
Q39770321 | Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-kappaB. |
Q83737658 | Growth performance and immune responses in chickens after challenge with lipopolysaccharide and modulation by dietary different oils |
Q38949434 | Gut Microbiota, Inflammation, and Colorectal Cancer. |
Q26774708 | Gut microbiota imbalance and colorectal cancer |
Q38190020 | H. pylori infection, inflammation and gastric cancer |
Q91996454 | HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models |
Q34618294 | HBx-induced NF-κB signaling in liver cells is potentially mediated by the ternary complex of HBx with p22-FLIP and NEMO. |
Q80805979 | HDAC2 deficiency sensitizes colon cancer cells to TNFalpha-induced apoptosis through inhibition of NF-kappaB activity |
Q42218400 | HPV16 E2-mediated potentiation of NF-κB activation induced by TNF-α involves parallel activation of STAT3 with a reduction in E2-induced apoptosis |
Q28393960 | Health promoting effects of brassica-derived phytochemicals: from chemopreventive and anti-inflammatory activities to epigenetic regulation |
Q35545513 | Heat shock transcription factor 1 is a key determinant of HCC development by regulating hepatic steatosis and metabolic syndrome |
Q55266043 | Heat-stress-modulated induction of NF-κB leads to brucellacidal pro-inflammatory defense against Brucella abortus infection in murine macrophages and in a mouse model. |
Q38194131 | Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer |
Q57753449 | Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment |
Q26782813 | Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions |
Q38721526 | Helicobacter pylori inhibits the cleavage of TRAF1 via a CagA-dependent mechanism |
Q42317062 | Helicteric Acid, Oleanic Acid, and Betulinic Acid, Three Triterpenes from Helicteres angustifolia L., Inhibit Proliferation and Induce Apoptosis in HT-29 Colorectal Cancer Cells via Suppressing NF-κB and STAT3 Signaling |
Q40004886 | Heme oxygenase 1 controls early innate immune response of macrophages to Salmonella Typhimurium infection. |
Q38116039 | Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses |
Q37983752 | Heparanase enzyme in chronic inflammatory bowel disease and colon cancer |
Q34876266 | Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice |
Q36545096 | Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis |
Q39767815 | Hepatocellular carcinoma repression by TNFα-mediated synergistic lethal effect of mitosis defect-induced senescence and cell death sensitization. |
Q87725770 | Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression |
Q33900418 | Herpes simplex virus 1 protein kinase US3 hyperphosphorylates p65/RelA and dampens NF-κB activation. |
Q38607613 | Hes1 expression and CYLD repression are essential events downstream of Notch1 in T-cell leukemia. |
Q39200116 | Heterozygous genetic variations of FOXP3 in Xp11.23 elevate breast cancer risk in Chinese population via skewed X-chromosome inactivation |
Q28383878 | Hexavalent chromium Cr(VI) up-regulates COX-2 expression through an NFκB/c-Jun/AP-1-dependent pathway |
Q35616490 | High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts |
Q49787779 | High RAC3 expression levels are required for induction and maintaining of cancer cell stemness. |
Q45345861 | High expression of Fibronectin 1 suppresses apoptosis through the NF-κB pathway and is associated with migration in nasopharyngeal carcinoma |
Q43199306 | High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis |
Q55307923 | High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway. |
Q41071204 | High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells. |
Q35531717 | High-Fat Diet-Induced Retinal Dysfunction |
Q36175681 | High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases |
Q33541291 | High-throughput and single-cell imaging of NF-kappaB oscillations using monoclonal cell lines |
Q36602323 | High-throughput proteomics reveal alarmins as amplifiers of tissue pathology and inflammation after spinal cord injury |
Q47161841 | Hispidulin-7-O-Neohesperidoside from Cirsium japonicum var. ussuriense Attenuates the Production of Inflammatory Mediators in LPS-Induced Raw 264.7 Cells and HT-29 Cells |
Q24681342 | Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL |
Q53184876 | Homeobox A9 directly targeted by miR-196b regulates aggressiveness through nuclear Factor-kappa B activity in non-small cell lung cancer cells. |
Q34658467 | Host gene expression profiling and in vivo cytokine studies to characterize the role of linezolid and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) murine sepsis model |
Q26745544 | How Mouse Macrophages Sense What Is Going On. |
Q28505337 | Hsp70 inhibits lipopolysaccharide-induced NF-kappaB activation by interacting with TRAF6 and inhibiting its ubiquitination |
Q39124267 | Hugl-1 induces apoptosis in esophageal carcinoma cells both in vitro and in vivo |
Q37641275 | Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice |
Q45388286 | Human T-cell leukemia virus type I tax down-regulates the expression of phosphatidylinositol 3,4,5-trisphosphate inositol phosphatases via the NF-kappaB pathway |
Q38359794 | Human activated macrophages and hypoxia: a comprehensive review of the literature |
Q33799921 | Human biliverdin reductase suppresses Goodpasture antigen-binding protein (GPBP) kinase activity: the reductase regulates tumor necrosis factor-alpha-NF-kappaB-dependent GPBP expression |
Q61448596 | Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins |
Q36216805 | Human papillomavirus genotypes in penile cancers from Japanese patients and HPV-induced NF-κB activation |
Q39445934 | Human papillomavirus infection induces NF-κB activation in cervical cancer: A comparison with penile cancer |
Q46015847 | Hyper-O-GlcNAcylation activates nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) signaling through interplay with phosphorylation and acetylation. |
Q30540051 | Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells |
Q36999112 | Hypoxic regulation of NF-kappaB signaling |
Q24292870 | IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer |
Q52687040 | ICAM3 mediates inflammatory signaling to promote cancer cell stemness. |
Q40331218 | IKK alpha regulates estrogen-induced cell cycle progression by modulating E2F1 expression |
Q24337225 | IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway |
Q33776852 | IKK is a therapeutic target in KRAS-Induced lung cancer with disrupted p53 activity |
Q33561833 | IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis |
Q39840485 | IKKbeta-mediated nuclear factor-kappaB activation attenuates smac mimetic-induced apoptosis in cancer cells |
Q50041873 | IKKα is required in the intestinal epithelial cells for tumour stemness. |
Q53236646 | IKKα promotes intestinal tumorigenesis by limiting recruitment of M1-like polarized myeloid cells. |
Q38438570 | IKKα-mediated biogenesis of miR-196a through interaction with Drosha regulates the sensitivity of cancer cells to radiotherapy |
Q37688677 | IKKβ inhibitor in combination with bortezomib induces cytotoxicity in breast cancer cells |
Q38256438 | IL-17 Expression by macrophages is associated with proliferative inflammatory atrophy lesions in prostate cancer patients |
Q38873952 | IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth |
Q36244747 | IL-1β-induced modulation of gene expression profile in human dermal fibroblasts: the effects of Thai herbal Sahatsatara formula, piperine and gallic acid possessing antioxidant properties |
Q29614594 | IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer |
Q62761935 | INH14, a Small-Molecule Urea Derivative, Inhibits the IKKα/β-Dependent TLR Inflammatory Response |
Q42269867 | IRAK4 turns IL-10+ phospho-FOXO+ monocytes into pro-inflammatory cells by suppression of protein kinase B. |
Q64954349 | IRX5 promotes NF-κB signalling to increase proliferation, migration and invasion via OPN in tongue squamous cell carcinoma. |
Q37691938 | ISG15 and immune diseases |
Q99412585 | Icariin-induced inhibition of SIRT6/NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in TNBC |
Q39402421 | Id-1 and the p65 subunit of NF-κB promote migration of nasopharyngeal carcinoma cells and are correlated with poor prognosis. |
Q40225454 | Id1 potentiates NF-kappaB activation upon T cell receptor signaling |
Q38131077 | Identification of MFG-E8 as a novel therapeutic target for diseases |
Q36984362 | Identification of TBK1 and IKKε, the non-canonical IκB kinases, as crucial pro-survival factors in HTLV-1-transformed T lymphocytes |
Q38923475 | Identification of a ligand-induced transient refractory period in nuclear factor-kappaB signaling. |
Q39659423 | Identification of a novel transport-independent function of PiT1/SLC20A1 in the regulation of TNF-induced apoptosis |
Q64068609 | Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma |
Q41612750 | Identification of deubiquitinase targets of isothiocyanates using SILAC-assisted quantitative mass spectrometry. |
Q90250087 | Identification of stable reference genes for lipopolysaccharide-stimulated macrophage gene expression studies |
Q26823854 | Identifying novel spatiotemporal regulators of innate immunity |
Q33294682 | IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway |
Q33529490 | IkappaBalpha polymorphism at promoter region (rs2233408) influences the susceptibility of gastric cancer in Chinese |
Q36715308 | Imbalanced network biomarkers for traditional Chinese medicine Syndrome in gastritis patients |
Q40208275 | Immediate early gene-X1 interferes with 26 S proteasome activity by attenuating expression of the 19 S proteasomal components S5a/Rpn10 and S1/Rpn2. |
Q92722005 | Immune senescence and immune activation in elderly colorectal cancer patients |
Q37097545 | Immune surveillance: a balance between protumor and antitumor immunity |
Q34025272 | Immunoglobulin responses at the mucosal interface. |
Q36780699 | Immunoinflammatory mechanisms in lung cancer development: is leptin a mediator? |
Q37974937 | Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment |
Q41866274 | Immunomodulatory effects of 17-O-acetylacuminolide in RAW264.7 cells and HUVECs: involvement of MAPK and NF-κB pathways |
Q33750160 | Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor |
Q46623243 | Immunosuppressive activity of alpinetin on activation and cytokines secretion of murine T lymphocytes |
Q29636247 | Immunosuppressive strategies that are mediated by tumor cells |
Q38068966 | Immunotherapy for head and neck cancer patients: shifting the balance |
Q34049388 | Impact of tumour associated macrophages in pancreatic cancer. |
Q35178414 | Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice |
Q38088360 | Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part II: targeting cell cycle events, caspases, NF-κB and the proteasome. |
Q64063487 | Importance of Incorporating Protein Flexibility in Molecule Modeling: A Theoretical Study on Type I NIK Inhibitors |
Q46106564 | Improved Biocompatibility of Black Phosphorus Nanosheets by Chemical Modification |
Q28476407 | In vitro and in vivo anti-inflammatory activity of 17-O-acetylacuminolide through the inhibition of cytokines, NF-κB translocation and IKKβ activity |
Q38287065 | In vitro micro-physiological models for translational immunology |
Q64055611 | In-depth characterization of the Wnt-signaling/β-catenin pathway in an in vitro model of Barrett's sequence |
Q37104726 | Inactivation of FIP200 leads to inflammatory skin disorder, but not tumorigenesis, in conditional knock-out mouse models |
Q36557300 | Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC). |
Q43081629 | Inciting inflammation: the RAGE about tumor promotion |
Q39984492 | Increased cytotoxicity by the combination of radiation and diospyrin diethylether in fibrosarcoma in culture and in tumor |
Q43747245 | Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen |
Q34141506 | Increased frequency of Mediterranean fever gene variants in multiple myeloma |
Q28478544 | Induction of Bcl-2 expression by hepatitis B virus pre-S2 mutant large surface protein resistance to 5-fluorouracil treatment in Huh-7 cells |
Q37039724 | Induction of Chronic Inflammation and Altered Levels of DNA Hydroxymethylation in Somatic and Germinal Tissues of CBA/CaJ Mice Exposed to (48)Ti Ions |
Q33900368 | Induction of TLR-2 and TLR-5 expression by Helicobacter pylori switches cagPAI-dependent signalling leading to the secretion of IL-8 and TNF-α. |
Q42292361 | Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli |
Q64120566 | Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol |
Q33555975 | Infections and cancer: the "fifty shades of immunity" hypothesis |
Q37668231 | Inflammation and EMT: an alliance towards organ fibrosis and cancer progression |
Q92444112 | Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites |
Q36393268 | Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression |
Q36393263 | Inflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice |
Q36597803 | Inflammation and colorectal cancer: colitis-associated neoplasia |
Q35091234 | Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer |
Q24644807 | Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion |
Q33653294 | Inflammation and oncogenesis: a vicious connection |
Q27345379 | Inflammation and proliferation act together to mediate intestinal cell fusion |
Q37250475 | Inflammation and stem cells in gastrointestinal carcinogenesis. |
Q37232937 | Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4 |
Q38425458 | Inflammation in Parkinson's disease: role of glucocorticoids. |
Q29620242 | Inflammation meets cancer, with NF-κB as the matchmaker |
Q35024882 | Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms |
Q89998669 | Inflammatory Cytokine TNFα Promotes the Long-Term Expansion of Primary Hepatocytes in 3D Culture |
Q26749801 | Inflammatory and oxidative stress in rotavirus infection |
Q44668087 | Inflammatory cells of immunosuppressive phenotypes in oral lichen planus have a proinflammatory pattern of expression and are associated with clinical parameters |
Q36523752 | Inflammatory events during murine squamous cell carcinoma development. |
Q37070898 | Influence of immunotherapy with autologous dendritic cells on innate and adaptive immune response in cancer. |
Q28388503 | Inhalation of environmental stressors & chronic inflammation: autoimmunity and neurodegeneration |
Q38516259 | Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma |
Q34205025 | Inhibiting NF-κB activation by small molecules as a therapeutic strategy |
Q40102265 | Inhibiting TRAF2-mediated activation of NF-kappaB facilitates induction of AP-1. |
Q58793793 | Inhibiting the CD8 T cell infiltration in the tumor microenvironment after radiotherapy is an important mechanism of radioresistance |
Q41514229 | Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation |
Q33270518 | Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency |
Q34561763 | Inhibition of NF-κB activation sensitizes U937 cells to 3'-azido-3'-deoxythymidine induced apoptosis |
Q47131486 | Inhibition of Pro-inflammatory and Anti-apoptotic Biomarkers during Experimental Oral Cancer Chemoprevention by Dietary Black Raspberries |
Q40286294 | Inhibition of RelA phosphorylation sensitizes apoptosis in constitutive NF-kappaB-expressing and chemoresistant cells |
Q36917707 | Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice |
Q38906936 | Inhibition of canonical NF-κB nuclear localization by (-)-DHMEQ via impairment of DNA binding |
Q39878770 | Inhibition of cyclin-dependent kinases by olomoucine and roscovitine reduces lipopolysaccharide-induced inflammatory responses via down-regulation of nuclear factor kappaB. |
Q37848684 | Inhibition of histone deacetylases in inflammatory bowel diseases |
Q39095137 | Inhibition of inflammatory mediators and reactive oxygen and nitrogen species by some depsidones and diaryl ether derivatives isolated from Corynespora cassiicola, an endophytic fungus of Gongronema latifolium leaves |
Q35096709 | Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells. |
Q34043446 | Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected] |
Q26824586 | Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation |
Q33953090 | Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity |
Q41575754 | Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers |
Q34754173 | Inhibitory effects of astaxanthin on azoxymethane-induced colonic preneoplastic lesions in C57/BL/KsJ-db/db mice |
Q58552990 | Inhibitory effects of pentoxifylline on inflammation-related tumorigenesis in rat colon |
Q57807665 | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets |
Q34614189 | Innate signaling networks in mucosal IgA class switching |
Q37994048 | Insulin-like growth factors and insulin: at the crossroad between tumor development and longevity |
Q37305074 | Integrating computational and biochemical studies to explore mechanisms in NF-{kappa}B signaling |
Q38084539 | Integrating dietary supplements into cancer care |
Q99409494 | Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer |
Q40055318 | Interferon-alpha induces transient upregulation of c-FLIP through NF-kappaB activation |
Q34012857 | Interferon-β signaling contributes to Ras transformation |
Q37081881 | Interleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cells |
Q38930857 | Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer. |
Q60916226 | Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma |
Q34989590 | Interplay between DNA repair and inflammation, and the link to cancer |
Q24307391 | Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties |
Q37501316 | Investigations of the functional states of dendritic cells under different conditioned microenvironments by Fourier transformed infrared spectroscopy |
Q33908674 | Involvement of NF-κB/IL-6 Pathway in the Processing of Colorectal Carcinogenesis in Colitis Mice |
Q24315943 | Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation |
Q53644644 | Ionizing radiation and leukaemia: more questions than answers. |
Q79314692 | Ionizing radiation stimulates secretion of pro-inflammatory cytokines: dose-response relationship, mechanisms and implications |
Q35223862 | Ionizing radiation, inflammation, and their interactions in colon carcinogenesis in Mlh1-deficient mice |
Q28388335 | Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases |
Q24570128 | Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls |
Q39869217 | Iso-seco-tanapartholides: Isolation, Synthesis and Biological Evaluation. |
Q64236794 | Isoalantolactone inhibits IKKβ kinase activity to interrupt the NF-κB/COX-2-mediated signaling cascade and induces apoptosis regulated by the mitochondrial translocation of cofilin in glioblastoma |
Q35049534 | Itk: the rheostat of the T cell response |
Q36397332 | IκB kinase ε phosphorylates TRAF2 to promote mammary epithelial cell transformation |
Q46430962 | Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice. |
Q37406535 | KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta |
Q50283025 | KIND1 Loss Sensitizes Keratinocytes to UV-Induced Inflammatory Response and DNA Damage |
Q34644229 | Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation. |
Q91742413 | Kin17 knockdown suppresses the migration and invasion of cervical cancer cells through NF-κB-Snail pathway |
Q61816324 | Knockdown of PHF5A Inhibits Migration and Invasion of HCC Cells via Downregulating NF-B Signaling |
Q36624048 | Knockout of phospholipase Cε attenuates N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumorigenesis |
Q36566015 | Krüppel-like factor-11, a transcription factor involved in diabetes mellitus, suppresses endothelial cell activation via the nuclear factor-κB signaling pathway. |
Q37317234 | LGR5 expression is controled by IKKα in basal cell carcinoma through activating STAT3 signaling pathway |
Q39695090 | LIGHT, a member of the TNF superfamily, activates Stat3 mediated by NIK pathway |
Q36841546 | LPS-induced NFκB enhanceosome requires TonEBP/NFAT5 without DNA binding |
Q33838924 | LPS-induced cytokine levels are repressed by elevated expression of HSP70 in rats: possible role of NF-kappaB |
Q61800291 | LUBAC determines chemotherapy resistance in squamous cell lung cancer |
Q38855550 | LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells |
Q46376244 | Leukotriene B4-receptor-1 mediated host response shapes gut microbiota and controls colon tumor progression |
Q35034303 | Limiting of the innate immune response by SF3A-dependent control of MyD88 alternative mRNA splicing |
Q35042272 | Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review). |
Q39849367 | Lipopolysaccharide-induced apoptosis in transformed bovine brain endothelial cells and human dermal microvessel endothelial cells: the role of JNK |
Q36984127 | Localization of A20 to a lysosome-associated compartment and its role in NFkappaB signaling |
Q51328387 | Long noncoding RNA-SRLR elicits intrinsic sorafenib resistance via evoking IL-6/STAT3 axis in renal cell carcinoma. |
Q35947858 | Loss of NDRG2 enhanced activation of the NF-κB pathway by PTEN and NIK phosphorylation for ATL and other cancer development. |
Q30432425 | Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans |
Q41243646 | Loss of Tff1 Promotes Pro-Inflammatory Phenotype with Increase in the Levels of RORγt+ T Lymphocytes and Il-17 in Mouse Gastric Neoplasia |
Q37276503 | Loss of estrogen-related receptor α promotes hepatocarcinogenesis development via metabolic and inflammatory disturbances. |
Q34770928 | Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation |
Q40521041 | Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc(min) mice. |
Q36386464 | Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines |
Q36526514 | Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy |
Q36891038 | Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance |
Q34080126 | Lupus serum IgG induces skin inflammation through the TNFR1 signaling pathway |
Q24652632 | Luteolin, a flavonoid with potential for cancer prevention and therapy |
Q34586289 | Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo |
Q27335708 | Lymphotoxin signaling is initiated by the viral polymerase in HCV-linked tumorigenesis |
Q52682420 | Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression. |
Q35737634 | Lysine392, a K63-linked ubiquitination site in NEMO, mediates inflammatory osteoclastogenesis and osteolysis |
Q34420804 | MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-kappaB signaling |
Q34700976 | MEKK3 expression correlates with nuclear factor kappa B activity and with expression of antiapoptotic genes in serous ovarian carcinoma |
Q40009131 | MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells: involvement of nuclear factor-kappaB and activator protein-1. |
Q26775996 | MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives |
Q38946767 | Macrophage activation by polysaccharides from Atractylodes macrocephala Koidz through the nuclear factor-κB pathway |
Q51209998 | Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction. |
Q29615847 | Macrophage diversity enhances tumor progression and metastasis |
Q54986341 | Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer. |
Q28068581 | Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma |
Q37993741 | Macrophage polarization and plasticity in health and disease |
Q36198192 | Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors |
Q37955105 | Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands. |
Q34507403 | Macrophages facilitate coal tar pitch extract-induced tumorigenic transformation of human bronchial epithelial cells mediated by NF-κB. |
Q34329242 | Macrophages in multiple myeloma: emerging concepts and therapeutic implications |
Q34824357 | Macrophages in the embryo and beyond: much more than just giant phagocytes. |
Q83042337 | Magnetic Fe₃O₄ nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells |
Q35904209 | Mammary tissue microenvironment determines T cell-dependent breast cancer-associated inflammation |
Q46307051 | Mapping normal and cancer cell signalling networks: towards single-cell proteomics |
Q21146681 | Maternal undernutrition and cardiometabolic disease: a Latin American perspective |
Q41576528 | Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development |
Q36696163 | Matrix metalloproteinase-9 inhibition down-regulates radiation-induced nuclear factor-kappa B activity leading to apoptosis in breast tumors |
Q41191469 | Matrix metalloproteinases and tissue inhibitor of metalloproteinases are essential for the inflammatory response in cancer cells |
Q35886583 | Mechanisms and pathways of innate immune activation and regulation in health and cancer |
Q37137367 | Mechanisms and therapeutic implications of cell death induction by indole compounds. |
Q34494043 | Mechanisms by Which Pleiotropic Amphiphilic n-3 PUFA Reduce Colon Cancer Risk |
Q37692380 | Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease |
Q36898702 | Mechanisms of disease: chronic inflammation and cancer in the pancreas--a potential role for pancreatic stellate cells? |
Q36490750 | Mechanisms of immune evasion by tumors |
Q38088305 | Mechanisms of the joint-protective effects of p38 MAPK inhibitors in rodent arthritis |
Q46081282 | Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation |
Q89607086 | Mechanistic understanding of β-cryptoxanthin and lycopene in cancer prevention in animal models |
Q39303608 | Melatonin MT1 receptor-induced transcriptional up-regulation of p27(Kip1) in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF-κB): potential implications on prostate cancer chemoprevent |
Q28391500 | Menopausal hormone therapy and lung cancer-specific mortality following diagnosis: the California Teachers Study |
Q37395883 | Mesenchymal stroma: primary determinant and therapeutic target for epithelial cancer |
Q37053471 | Metallothionein 2A inhibits NF-κB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection |
Q84098237 | Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression |
Q39251789 | MiR-26a regulates cell cycle and anoikis of human esophageal adenocarcinoma cells through Rb1-E2F1 signaling pathway |
Q50117508 | MiRNAs at the Crossroads between Innate Immunity and Cancer: Focus on Macrophages |
Q24648543 | MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components |
Q36090085 | MicroRNA-125b-5p suppresses Brucella abortus intracellular survival via control of A20 expression. |
Q90733672 | MicroRNA-139-5p regulates chronic inflammation by suppressing nuclear factor-κB activity to inhibit cell proliferation and invasion in colorectal cancer |
Q45854940 | MicroRNA-146b improves intestinal injury in mouse colitis by activating nuclear factor-κB and improving epithelial barrier function |
Q38288067 | MicroRNA-181a-5p Impedes IL-17-Induced Nonsmall Cell Lung Cancer Proliferation and Migration through Targeting VCAM-1. |
Q24289060 | MicroRNA-19b-3p Modulates Japanese Encephalitis Virus-Mediated Inflammation via Targeting RNF11 |
Q35965465 | MicroRNA-7/NF-κB signaling regulatory feedback circuit regulates gastric carcinogenesis. |
Q24630097 | MicroRNAs in NF-kappaB signaling |
Q57300026 | Microbial Changes and Host Response in F344 Rat Colon Depending on Sex and Age Following a High-Fat Diet |
Q55554558 | Microbiota, Epithelium, Inflammation, and TGF-β Signaling: An Intricate Interaction in Oncogenesis. |
Q37273162 | Milk fat globule epidermal growth factor-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms |
Q51765947 | Mining the nucleus accumbens proteome for novel targets of alcohol self-administration in male C57BL/6J mice. |
Q50785469 | Mitigation of Radiation-Induced Epithelial Damage by the TLR5 Agonist Entolimod in a Mouse Model of Fractionated Head and Neck Irradiation. |
Q38544785 | Mitochondrial Ca(2+) Remodeling is a Prime Factor in Oncogenic Behavior |
Q58556263 | Mitochondrial dysfunction in cancer |
Q38064965 | Mitochondrial neuronal uncoupling proteins: a target for potential disease-modification in Parkinson's disease |
Q40102576 | MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release. |
Q42705995 | Modulation of microRNA expression by volatile organic compounds in mouse lung |
Q40224980 | Modulation of transcription factor NF-kappaB in Hodgkin's lymphoma cell lines: effect of (-)-epicatechin |
Q92589397 | Molecular Mechanisms of Cancer-Induced Sleep Disruption |
Q36803861 | Molecular analysis of the bovine anaphylatoxin C5a receptor |
Q35740772 | Molecular damage in cancer: an argument for mTOR-driven aging |
Q34384889 | Molecular marker identification for relapse prediction in 5-FU-based adjuvant chemotherapy in gastric and colorectal cancers |
Q24655100 | Molecular mechanisms involved in farnesol-induced apoptosis |
Q37605343 | Molecular mechanisms underlying chronic inflammation-associated cancers |
Q30369661 | Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling. |
Q37393034 | Monitoring the autophagy pathway in cancer |
Q36167571 | Monocyte and macrophage plasticity in tissue repair and regeneration |
Q90043574 | Monocytes and Macrophages in Cancer: Unsuspected Roles |
Q37022872 | Monocytes mediate metastatic breast tumor cell adhesion to endothelium under flow |
Q39402873 | Mountain ginseng extract exhibits anti-lung cancer activity by inhibiting the nuclear translocation of NF-κB. |
Q24633765 | Mucins in cancer: function, prognosis and therapy |
Q41919605 | Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Positively Modulates Matrix Metalloproteinase-9 Production in Alveolar Macrophages upon Toll-Like Receptor 7 Signaling and Influenza Virus Infection |
Q28390894 | Multi-walled carbon nanotube induces nitrative DNA damage in human lung epithelial cells via HMGB1-RAGE interaction and Toll-like receptor 9 activation |
Q35890732 | Multiple Mechanisms of Anti-Cancer Effects Exerted by Astaxanthin |
Q36973287 | Multiple endocrine neoplasia type 1 (MEN1) as a cancer predisposition syndrome: clues into the mechanisms of MEN1-related carcinogenesis |
Q27008380 | Multiple roles of toll-like receptor 4 in colorectal cancer |
Q39388171 | Multiplexed cytokine profiling of serum for detection of colorectal cancer |
Q36544693 | Mutation of cysteine 46 in IKK-beta increases inflammatory responses |
Q34768240 | Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation |
Q50972710 | Myeloid TGF-β signaling contributes to colitis-associated tumorigenesis in mice. |
Q39170190 | Myeloid cell RelA/p65 promotes lung cancer proliferation through Wnt/β-catenin signaling in murine and human tumor cells. |
Q30412099 | Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors |
Q42408323 | Myeloid cells in tumor inflammation |
Q41978406 | Myeloid-derived cullin 3 promotes STAT3 phosphorylation by inhibiting OGT expression and protects against intestinal inflammation. |
Q39104155 | Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract |
Q36718219 | NEMO Prevents RIP Kinase 1-Mediated Epithelial Cell Death and Chronic Intestinal Inflammation by NF-κB-Dependent and -Independent Functions |
Q53609454 | NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage. |
Q46535142 | NF-kappaB activation by the viral oncoprotein StpC enhances IFN-gamma production in T cells |
Q36725293 | NF-kappaB activation in development and progression of cancer |
Q33744644 | NF-kappaB activation in hypothalamic pro-opiomelanocortin neurons is essential in illness- and leptin-induced anorexia |
Q34033879 | NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement |
Q37721657 | NF-kappaB fans the flames of lung carcinogenesis |
Q37163422 | NF-kappaB in inflammatory bowel disease |
Q28611413 | NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target |
Q37480036 | NF-kappaB regulation: the nuclear response |
Q37293337 | NF-kappaB signaling pathway and its therapeutic implications in human diseases |
Q37701897 | NF-kappaB signaling: multiple angles to target OA. |
Q36711178 | NF-kappaB-dependent transcriptional activation in lung carcinoma cells by farnesol involves p65/RelA(Ser276) phosphorylation via the MEK-MSK1 signaling pathway. |
Q33878632 | NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma |
Q35900991 | NF-kappaB2 mutation targets TRAF1 to induce lymphomagenesis |
Q50956905 | NF-κB Members Left Home: NF-κB-Independent Roles in Cancer. |
Q36179538 | NF-κB and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis |
Q37374081 | NF-κB as a Target for Oncogenic Viruses |
Q37981941 | NF-κB as a potential therapeutic target in microbial diseases |
Q60301375 | NF-κB p65 and p105 implicate in interleukin 1β-mediated COX-2 expression in melanoma cells |
Q37691276 | NF-κB signaling |
Q49594691 | NF-κB, inflammation, immunity and cancer: coming of age. |
Q35260971 | NF-κB-Mediated Regulation of Osteoclastogenesis |
Q50112594 | NF-κB/miR-223-3p/ARID1A axis is involved in Helicobacter pylori CagA-induced gastric carcinogenesis and progression |
Q35994472 | NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function |
Q34285220 | NF-κB2 mutation targets survival, proliferation and differentiation pathways in the pathogenesis of plasma cell tumors |
Q42411008 | NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity |
Q93009350 | NFкB is a critical transcriptional regulator of atypical cadherin FAT1 in glioma |
Q55457074 | NLRP3 promotes glioma cell proliferation and invasion via the interleukin-1β/NF-κB p65 signals. |
Q37185879 | NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice |
Q33907548 | NOD-like receptors in intestinal homeostasis and epithelial tissue repair |
Q33808220 | NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-κB. |
Q64981459 | NSE from diffuse large B-cell lymphoma cells regulates macrophage polarization. |
Q89108705 | Naloxone attenuates ischemic brain injury in rats through suppressing the NIK/IKKα/NF-κB and neuronal apoptotic pathways |
Q47363228 | Nanoparticle distribution during systemic inflammation is size-dependent and organ-specific |
Q24298148 | Negative regulation of protein phosphatase 2Cbeta by ISG15 conjugation |
Q36306990 | Nemo-like kinase (NLK) negatively regulates NF-kappa B activity through disrupting the interaction of TAK1 with IKKβ. |
Q33575787 | Networks inferred from biochemical data reveal profound differences in toll-like receptor and inflammatory signaling between normal and transformed hepatocytes |
Q28066130 | Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis |
Q36156573 | Neuronal RING finger protein 11 (RNF11) regulates canonical NF-κB signaling |
Q24612339 | Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model |
Q38810648 | New directions in poly(ADP-ribose) polymerase biology |
Q38032236 | New insight into the oncogenic mechanism of the retroviral oncoprotein Tax. |
Q36845724 | New technologies used in the study of human melanoma |
Q37943790 | Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go? |
Q53341929 | Nickel compounds render anti-apoptotic effect to human bronchial epithelial Beas-2B cells by induction of cyclooxygenase-2 through an IKKbeta/p65-dependent and IKKalpha- and p50-independent pathway. |
Q28389269 | Nickel-induced down-regulation of ΔNp63 and its role in the proliferation of keratinocytes |
Q96952231 | Nitrative DNA damage in lung epithelial cells exposed to indium nanoparticles and indium ions |
Q37710978 | Nitric oxide and calcium signaling regulate myocardial tumor necrosis factor-α expression and cardiac function in sepsis |
Q38875536 | Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome |
Q36680965 | Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort |
Q37840104 | Novel IkB kinase inhibitors for treatment of nuclear factor-kB-related diseases |
Q34277985 | Novel anti-inflammatory activity of epoxyazadiradione against macrophage migration inhibitory factor: inhibition of tautomerase and proinflammatory activities of macrophage migration inhibitory factor |
Q40186974 | Novel insights into the cellular mechanisms of the anti-inflammatory effects of NF-kappaB essential modulator binding domain peptides |
Q53111716 | Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancer. |
Q36018005 | Nrf2 and NF-κB Signaling Pathways Contribute to Porphyra-334-Mediated Inhibition of UVA-Induced Inflammation in Skin Fibroblasts |
Q34209307 | Nuclear Factor-κB modulates cellular glutathione and prevents oxidative stress in cancer cells |
Q34303188 | Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein |
Q79758484 | Nuclear bile acid receptor farnesoid X receptor meets nuclear factor-kappaB: new insights into hepatic inflammation |
Q38196790 | Nuclear factor-kappa-B signaling in lung development and disease: one pathway, numerous functions |
Q33648301 | Nuclear factor-kappaB (NF-kappaB) is a novel positive transcriptional regulator of the oncogenic Wip1 phosphatase |
Q79320536 | Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions |
Q37681941 | Nuclear factor-kappaB and tumor-associated macrophages |
Q29547879 | Nuclear factor-kappaB in cancer development and progression |
Q38838562 | Nucleotide-binding oligomerization domain 2 (NOD2) activation induces apoptosis of human oral squamous cell carcinoma cells |
Q37307180 | Nutrients and risk of colon cancer |
Q28079556 | Obesity and colorectal cancer: molecular features of adipose tissue |
Q42076725 | Obesity promotes colonic stem cell expansion during cancer initiation |
Q64057162 | Obesity, DNA Damage, and Development of Obesity-Related Diseases |
Q37325202 | Olfactomedin 4 deletion induces colon adenocarcinoma in Apc(Min/+) mice |
Q39579099 | Oligomannurarate sulfate sensitizes cancer cells to doxorubicin by inhibiting atypical activation of NF-κB via targeting of Mre11. |
Q39355041 | Oncogenic PI3K mutations lead to NF-κB-dependent cytokine expression following growth factor deprivation |
Q40977712 | Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway. |
Q36413217 | Opposed expression of IKKα: loss in keratinizing carcinomas and gain in non-keratinizing carcinomas |
Q36937167 | Opposing functions of IKKbeta during acute and chronic intestinal inflammation |
Q35945066 | Optical imaging of tumor cells in hollow fibers: evaluation of the antitumor activities of anticancer drugs and target validation |
Q38089835 | Optical molecular imaging in drug discovery and clinical development |
Q47330933 | Oral Cancer Stem Cells Microenvironment. |
Q36543791 | Order, disorder, death: lessons from a superorganism |
Q39285343 | Oroxylin A prevents inflammation-related tumor through down-regulation of inflammatory gene expression by inhibiting NF-κB signaling |
Q90400168 | Over-expression of nuclear factor-κB family genes and inflammatory molecules is related to chronic obstructive pulmonary disease |
Q36982546 | Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. |
Q35195028 | Overexpression of the human ZNF300 gene enhances growth and metastasis of cancer cells through activating NF-kB pathway |
Q37729938 | Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment |
Q36039273 | Oxidative stress promotes myofibroblast differentiation and tumour spreading |
Q41949753 | Oxymatrine reduces neuroinflammation in rat brain: A signaling pathway |
Q99630289 | P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer |
Q42264428 | PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment. |
Q37618064 | PHF20 regulates NF-κB signalling by disrupting recruitment of PP2A to p65 |
Q55007045 | PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation. |
Q40244068 | PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. |
Q42378816 | PKCε phosphorylates MIIP and promotes colorectal cancer metastasis through inhibition of RelA deacetylation |
Q38537351 | PLCε signaling in cancer |
Q37021709 | PPARs Mediate Lipid Signaling in Inflammation and Cancer |
Q34100984 | PTEN loss induces epithelial--mesenchymal transition in human colon cancer cells. |
Q39247664 | PTEN/MAPK pathways play a key role in platelet-activating factor-induced experimental pulmonary tumor metastasis |
Q35091196 | Pattern of transcription factor activation in Helicobacter pylori-infected Mongolian gerbils |
Q36548470 | Pattern recognition receptors: a contemporary view on liver diseases. |
Q54645079 | Peering into the aftermath: JAKi rips STAT3 in cancer. |
Q37543936 | Peptides genetically selected for NF-κB activation cooperate with oncogene Ras and model carcinogenic role of inflammation |
Q36261424 | Perfluorooctanoic acid enhances colorectal cancer DLD-1 cells invasiveness through activating NF-κB mediated matrix metalloproteinase-2/-9 expression |
Q24312920 | Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors |
Q41878187 | Perspective: alpha-bugs, their microbial partners, and the link to colon cancer |
Q38853680 | Pharmacological Modulation of Proton Channel Hv1 in Cancer Therapy: Future Perspectives. |
Q35849330 | Pharmacological basis of the use of the root bark of Zizyphus nummularia Aubrev. (Rhamnaceae) as anti-inflammatory agent. |
Q36125880 | Phenotypic MicroRNA Microarrays |
Q47105970 | Phenotypic heterogeneity in modeling cancer evolution. |
Q52804185 | Phosphanegold(I) thiolates, Ph3PAu[SC(OR)=NC 6H 4Me-4] for R = Me, Et and iPr, induce apoptosis, cell cycle arrest and inhibit cell invasion of HT-29 colon cancer cells through modulation of the nuclear factor-κB activation pathway and ubiquitinatio |
Q37116334 | Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect |
Q47112561 | Phosphorylation at S153 as a Functional Switch of Phosphatidylethanolamine Binding Protein 1 in Cerebral Ischemia-Reperfusion Injury in Rats. |
Q30425294 | Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1. |
Q33456429 | Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation |
Q36433070 | Phytochemicals of Aristolochia tagala and Curcuma caesia exert anticancer effect by tumor necrosis factor-α-mediated decrease in nuclear factor kappaB binding activity |
Q28394743 | Piperlongumine inhibits lung tumor growth via inhibition of nuclear factor kappa B signaling pathway |
Q38761817 | Plantamajoside Inhibits UVB and Advanced Glycation End Products-Induced MMP-1 Expression by Suppressing the MAPK and NF-κB Pathways in HaCaT Cells |
Q55090047 | Plasmodium circumsporozoite protein suppresses the growth of A549 cells via inhibiting nuclear transcription factor κB. |
Q45253920 | Platelet-activating factor enhances tumour metastasis via the reactive oxygen species-dependent protein kinase casein kinase 2-mediated nuclear factor-κB activation |
Q37154190 | Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells |
Q61807253 | Platelet-rich plasma plays an antibacterial, anti-inflammatory and cell proliferation-promoting role in an in vitro model for diabetic infected wounds |
Q36808629 | Polarized immune responses differentially regulate cancer development |
Q64935031 | Poly(I:C) stimulation is superior than Imiquimod to induce the antitumoral functional profile of tumor-conditioned macrophages. |
Q28395397 | Polymorphisms in the CHIT1 gene: Associations with colorectal cancer |
Q40751696 | Polymorphisms of NFκB1 and IκBα and Their Synergistic Effect on Nasopharyngeal Carcinoma Susceptibility |
Q34084838 | Polymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers. |
Q64076444 | Positive Immuno-Modulation Following Radiofrequency Assisted Liver Resection in Hepatocellular Carcinoma |
Q37524210 | Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity |
Q37799995 | Potential of the dietary antioxidants resveratrol and curcumin in prevention and treatment of hematologic malignancies. |
Q37944053 | Potential role of antioxidant food supplements, preservatives and colorants in the pathogenesis of allergy and asthma |
Q34594807 | Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases |
Q39391684 | Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy. |
Q34937087 | Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells |
Q85857629 | Predictive role of levels of soluble interleukin-2 receptor and C-reactive protein in selecting autologous PBSC transplantation for lymphoma |
Q89931341 | Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer |
Q37306894 | Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268. |
Q34630418 | Primary intraosseous squamous cell carcinoma arising in an odontogenic cyst: a clinicopathologic analysis of 116 reported cases |
Q38980308 | Pro-angiogenic effects of MDM2 through HIF-1α and NF-κB mediated mechanisms in LNCaP prostate cancer cells |
Q40004010 | Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kappaB and MAPK signalling |
Q34407019 | Profiling microRNAs in lung tissue from pigs infected with Actinobacillus pleuropneumoniae |
Q38296730 | Profiling of promoter occupancy by the SND1 transcriptional coactivator identifies downstream glycerolipid metabolic genes involved in TNFα response in human hepatoma cells |
Q61804254 | Prognostic value of multiple cytokine analysis in colorectal cancer: a systematic review |
Q35346509 | Prognostic value, clinicopathologic features and diagnostic accuracy of interleukin-8 in colorectal cancer: a meta-analysis |
Q35526008 | Programmable oligomers targeting 5'-GGGG-3' in the minor groove of DNA and NF-kappaB binding inhibition |
Q34303405 | Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis |
Q24658240 | Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells |
Q35141643 | Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity |
Q42750201 | Proteasome activity is required for the initiation of precancerous pancreatic lesions. |
Q39510395 | Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell lines |
Q89552854 | Protective Effect of Amygdalin on LPS-Induced Acute Lung Injury by Inhibiting NF-κB and NLRP3 Signaling Pathways |
Q91670292 | Protective Role of Fecal Microbiota Transplantation on Colitis and Colitis-Associated Colon Cancer in Mice Is Associated With Treg Cells |
Q88499139 | Protective and Therapeutic Effects of Engeletin on LPS-Induced Acute Lung Injury |
Q34941380 | Protective effects of hypothalamic beta-endorphin neurons against alcohol-induced liver injuries and liver cancers in rat animal models |
Q90243732 | Protein interaction disruption in cancer |
Q53228203 | Proteome profiling of keratinocytes transforming to malignancy. |
Q37247067 | Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1. |
Q43832946 | Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8. |
Q48174470 | Quinacrine Inhibits ICAM-1 Transcription by Blocking DNA Binding of the NF-κB Subunit p65 and Sensitizes Human Lung Adenocarcinoma A549 Cells to TNF-α and the Fas Ligand |
Q35102969 | RAGE Signaling Significantly Impacts Tumorigenesis and Hepatic Tumor Growth in Murine Models of Colorectal Carcinoma |
Q36502858 | RAGE signaling sustains inflammation and promotes tumor development |
Q24658378 | RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis |
Q36544139 | RASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma |
Q40050346 | RIP1 links inflammatory and growth factor signaling pathways by regulating expression of the EGFR. |
Q54977091 | RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway. |
Q92221569 | RNA helicase p68 deploys β-catenin in regulating RelA/p65 gene expression: implications in colon cancer |
Q39279441 | RNF11 modulates microglia activation through NF-κB signalling cascade |
Q42117551 | Radiation-induced glioblastoma signaling cascade regulates viability, apoptosis and differentiation of neural stem cells (NSC). |
Q43572477 | Rage signalling promotes intestinal tumourigenesis |
Q33795121 | Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models. |
Q50716567 | Real-time studies of the progression of bacterial infections and immediate tissue responses in live animals. |
Q34152899 | Recent insights into the role of NF-kappaB in ovarian carcinogenesis |
Q37113463 | Receptor-drug interaction: europium employment for studying the biochemical pathway of g-protein-coupled receptor activation |
Q36124088 | Reduction of inflammatory bowel disease-induced tumor development in IL-10 knockout mice with soluble epoxide hydrolase gene deficiency |
Q39277317 | Regulation of Gastric Metaplasia, Dysplasia, and Neoplasia by Bone Morphogenetic Protein Signaling |
Q36180432 | Regulation of IL-20 Expression by Estradiol through KMT2B-Mediated Epigenetic Modification |
Q36483396 | Regulation of MyD88-dependent signaling events by S nitrosylation retards toll-like receptor signal transduction and initiation of acute-phase immune responses |
Q28511500 | Regulation of NF-κB activity by competition between RelA acetylation and ubiquitination |
Q38298517 | Regulation of angiogenesis by aminoacyl-tRNA synthetases |
Q45410310 | Regulation of human glioblastoma cell death by combined treatment of cannabidiol, γ-radiation and small molecule inhibitors of cell signaling pathways |
Q36999102 | Regulation of hypoxia-inducible factors during inflammation |
Q37378324 | Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. |
Q28512135 | Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88 |
Q36677304 | Regulation of tumor necrosis factor receptor-1 and the IKK-NF-kappaB pathway by LDL receptor-related protein explains the antiinflammatory activity of this receptor |
Q38948512 | Regulatory T Cells and Cancer: A Two-Sided Story |
Q36534827 | Regulatory T cells and innate immune regulation in tumor immunity |
Q37023880 | Regulatory potential for concerted modulation of Nrf2- and Nfkb1-mediated gene expression in inflammation and carcinogenesis |
Q36217010 | Relationship among human papillomavirus infection, p16(INK4a), p53 and NF-κB activation in penile cancer from northern Thailand |
Q35192591 | Requirement of FADD, NEMO, and BAX/BAK for aberrant mitochondrial function in tumor necrosis factor alpha-induced necrosis |
Q38217707 | Research progress in signalling pathway in diabetic nephropathy |
Q40198109 | Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4. |
Q47584718 | Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus |
Q90009252 | Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells |
Q36324806 | Resveratrol Protects against Helicobacter pylori-Associated Gastritis by Combating Oxidative Stress |
Q43162195 | Resveratrol and piceatannol inhibit iNOS expression and NF-kappaB activation in dextran sulfate sodium-induced mouse colitis |
Q34058331 | Retracted: Plexin-B1 Activates NF-κB and IL-8 to Promote a Pro-Angiogenic Response in Endothelial Cells |
Q26749322 | Review: the Contribution of both Nature and Nurture to Carcinogenesis and Progression in Solid Tumours |
Q24324531 | Ro52-mediated monoubiquitination of IKK{beta} down-regulates NF-{kappa}B signalling |
Q27312487 | Role for sumoylation in systemic inflammation and immune homeostasis in Drosophila larvae |
Q52569931 | Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. |
Q42350897 | Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder. |
Q36439041 | Role of chronic E. coli infection in the process of bladder cancer- an experimental study |
Q64974753 | Role of epigenetics in transformation of inflammation into colorectal cancer. |
Q38542147 | Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease |
Q37710885 | Role of estrogen in hepatocellular carcinoma: is inflammation the key? |
Q36303643 | Role of macrophage migration inhibitory factor in the regulatory T cell response of tumor-bearing mice |
Q33750847 | Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min/+) mice |
Q38041500 | Role of nuclear factor-ĸB in breast and colorectal cancer |
Q92724115 | Role of the COP9 Signalosome (CSN) in Cardiovascular Diseases |
Q38042019 | Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer |
Q28073131 | Role of the Microbiota in Colorectal Cancer: Updates on Microbial Associations and Therapeutic Implications |
Q39914415 | Role of the nervous system in cancer metastasis. |
Q47237527 | Roles of Heat Shock Proteins in Apoptosis, Oxidative Stress, Human Inflammatory Diseases, and Cancer |
Q52722878 | Roles of NF-κB Signaling in the Regulation of miRNAs Impacting on Inflammation in Cancer. |
Q92868309 | Roles of the hexosamine biosynthetic pathway and pentose phosphate pathway in bile acid-induced cancer development |
Q34413441 | Roles of tumor suppressors in regulating tumor-associated inflammation |
Q92725333 | S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop |
Q37376360 | S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide |
Q39814040 | S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. |
Q34802977 | S100A8/A9 activate key genes and pathways in colon tumor progression |
Q37164343 | SAG-UPS attenuates proapoptotic SARM and Noxa to confer survival advantage to early hepatocellular carcinoma |
Q35228761 | SCF(JFK) is a bona fide E3 ligase for ING4 and a potent promoter of the angiogenesis and metastasis of breast cancer |
Q54485665 | SJSZ glycoprotein (38 kDa) modulates macrophage type 1/2-related factors at hepatocarcinogenic stage in N-nitrosodiethylamine-treated Balb/c. |
Q50074498 | SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-κB-CD47 axis |
Q36771328 | STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy. |
Q26998940 | STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer |
Q37162367 | STAT3 in epithelial cells regulates inflammation and tumor progression to malignant state in colon. |
Q29547203 | STATs in cancer inflammation and immunity: a leading role for STAT3 |
Q90874251 | Sam68 impedes the recovery of arterial injury by augmenting inflammatory response |
Q39230324 | Santonin-related compound 2 inhibits the nuclear translocation of NF-κB subunit p65 by targeting cysteine 38 in TNF-α-induced NF-κB signaling pathway |
Q47599401 | Sarcopenia is associated with an increased risk of advanced colorectal neoplasia |
Q36478254 | Screening for the Key lncRNA Targets Associated With Metastasis of Renal Clear Cell Carcinoma |
Q37687457 | Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells |
Q33799457 | Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB |
Q33329753 | Selection and characterization of anti-NF-kappaB p65 RNA aptamers |
Q37626577 | Selective TBK1/IKKi dual inhibitors with anticancer potency |
Q39029981 | Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-κB p65 to evoke reactive oxygen species generation and p53 activation |
Q36966767 | Selectively targeting the toll-like receptor 9 (TLR9)--IRF 7 signaling pathway by polymer blend particles |
Q37702727 | Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling |
Q40006395 | Sequestration of NF-kappaB signaling complexes in lipid rafts contributes to repression of NF-kappaB in T lymphocytes under hyperthermia stress |
Q39909557 | Sequestration of PDLIM2 in the cytoplasm of monocytic/macrophage cells is associated with adhesion and increased nuclear activity of NF-kappaB. |
Q34130898 | Sharpin contributes to TNFα dependent NFκB activation and anti-apoptotic signalling in hepatocytes |
Q36546794 | Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome |
Q64119071 | Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication |
Q40087723 | Signal responsiveness of IkappaB kinases is determined by Cdc37-assisted transient interaction with Hsp90. |
Q36492439 | Signal transduction of inflammatory cytokines and tumor development |
Q33755839 | Signaling pathways in cartilage repair |
Q35606024 | Signatures of human regulatory T cells: an encounter with old friends and new players |
Q36101233 | Significance of heparanase in cancer and inflammation |
Q57788138 | Silence of Stomatin-Like Protein 2 Represses Migration and Invasion Ability of Human Liver Cancer Cells via Inhibiting the Nuclear Factor Kappa B (NF-κB) Pathway |
Q39178106 | Silver-based nanoparticles induce apoptosis in human colon cancer cells mediated through p53. |
Q93169465 | Simvastatin Nanoparticles Reduce Inflammation in LPS-Stimulated Alveolar Macrophages |
Q35220630 | Single hind limb burn injury to mice alters nuclear factor-κB expression and [¹⁸F] 2-fluoro-2-deoxy-D-glucose uptake |
Q34542388 | Single-cell and population NF-κB dynamic responses depend on lipopolysaccharide preparation |
Q40355223 | Site-specific monoubiquitination of IkappaB kinase IKKbeta regulates its phosphorylation and persistent activation |
Q36899787 | Sleep loss activates cellular inflammatory signaling |
Q55214898 | Sleeping Beauty and the Microenvironment Enchantment: Microenvironmental Regulation of the Proliferation-Quiescence Decision in Normal Tissues and in Cancer Development. |
Q35835217 | Snail interacts with Id2 in the regulation of TNF-α-induced cancer cell invasion and migration in OSCC. |
Q33781020 | Social network ties and inflammation in U.S. adults with cancer |
Q39712901 | Soluble HLA-G induces NF-kappaB activation in natural killer cells. |
Q57044552 | Sorafenib inhibits caspase-1 expression through suppressing TLR4/stat3/SUMO1 pathway in hepatocellular carcinoma |
Q27675967 | Specific recognition of linear ubiquitin chains by the Npl4 zinc finger (NZF) domain of the HOIL-1L subunit of the linear ubiquitin chain assembly complex |
Q91666430 | Spliceosome protein Eftud2 promotes colitis-associated tumorigenesis by modulating inflammatory response of macrophage |
Q36819933 | Src family kinases and lipid mediators in control of allergic inflammation |
Q24321517 | Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion |
Q34624443 | Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation |
Q37972656 | Stat3: linking inflammation to (gastrointestinal) tumourigenesis |
Q33921803 | Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling? |
Q36889332 | Stress signaling in cancer. |
Q40072016 | Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment |
Q46544116 | Stromal signatures in endometrioid endometrial carcinomas. |
Q90152398 | Studying the effects of several heat-inactivated bacteria on colon and breast cancer cells |
Q89869413 | Subcellular western blotting of single cells |
Q35021987 | Substrate cleavage profiling suggests a distinct function of Bacteroides fragilis metalloproteinases (fragilysin and metalloproteinase II) at the microbiome-inflammation-cancer interface |
Q39254514 | Subverting Host Cell P21-Activated Kinase: A Case of Convergent Evolution across Pathogens |
Q50978979 | Succinamide derivatives of melampomagnolide B and their anti-cancer activities. |
Q30449201 | Suicidal gene therapy in an NF-κB-controlled tumor environment as monitored by a secreted blood reporter |
Q37497981 | Sulindac activates NF-κB signaling in colon cancer cells |
Q36425868 | Sumoylation is tumor-suppressive and confers proliferative quiescence to hematopoietic progenitors in Drosophila melanogaster larvae |
Q40188580 | Suppression of NF-kappaB and AP-1 activation in monocytic cells persistently infected with measles virus |
Q35414780 | Survivin and IAP proteins in cell-death mechanisms |
Q42050158 | Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1. |
Q28396388 | Sustained proliferation in cancer: Mechanisms and novel therapeutic targets |
Q33703901 | Synbindin in extracellular signal-regulated protein kinase spatial regulation and gastric cancer aggressiveness |
Q36325314 | Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma |
Q47787057 | Synergistic effect of baicalein, wogonin and oroxylin A mixture: multistep inhibition of the NF-κB signalling pathway contributes to an anti-inflammatory effect of Scutellaria root flavonoids. |
Q37149856 | Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth |
Q40082885 | TAK1 is required for TGF-beta 1-mediated regulation of matrix metalloproteinase-9 and metastasis. |
Q35169027 | TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cells |
Q36868764 | TAT-mediated intracellular delivery of NPM-derived peptide induces apoptosis in leukemic cells and suppresses leukemogenesis in mice |
Q24316100 | TC1 (C8orf4) is upregulated by cellular stress and mediates heat shock response |
Q38312850 | TC1(C8orf4) is upregulated by IL-1beta/TNF-alpha and enhances proliferation of human follicular dendritic cells |
Q36659217 | TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets. |
Q36108579 | TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis |
Q36850457 | TLR agonists: our best frenemy in cancer immunotherapy |
Q28291637 | TLR signaling |
Q37490923 | TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases |
Q41391981 | TLR7 inhibition: A novel strategy for pancreatic cancer treatment? |
Q28389414 | TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis |
Q36121743 | TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice |
Q34835806 | TNF-alpha-dependent loss of IKKbeta-deficient myeloid progenitors triggers a cytokine loop culminating in granulocytosis |
Q37678189 | TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion |
Q34480157 | TNFalpha induces ABCA1 through NF-kappaB in macrophages and in phagocytes ingesting apoptotic cells |
Q37769438 | TRAF-mediated regulation of immune and inflammatory responses |
Q33794121 | TRAF2 is an NF-κB-activating oncogene in epithelial cancers. |
Q40035477 | TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis |
Q98568662 | TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα |
Q24299200 | TRIM40 promotes neddylation of IKKγ and is downregulated in gastrointestinal cancers |
Q38668064 | TWEAK/Fn14 signaling in tumors |
Q37315118 | Targeted overexpression of vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer |
Q27002288 | Targeted therapy for hepatocellular carcinoma: novel agents on the horizon |
Q34067270 | Targeted tumor necrosis factor receptor I preligand assembly domain improves skin lesions in MRL/lpr mice |
Q52372117 | Targeting IκappaB kinases for cancer therapy. |
Q99594459 | Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study |
Q37731951 | Targeting TLR/IL-1R signalling in human diseases. |
Q38125500 | Targeting cancer stem cells with sulforaphane, a dietary component from broccoli and broccoli sprouts |
Q39007389 | Targeting colon cancer cell NF-κB promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis |
Q36653657 | Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis |
Q35155622 | Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer |
Q38028572 | Targeting kinases for the treatment of inflammatory diseases |
Q37415794 | Targeting of the Akt-nuclear factor-kappa B signaling network by [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a novel indole-3-carbinol derivative, in a mouse model of hepatocellular carcinoma |
Q37286190 | Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology |
Q39438509 | Targeting radioresistant osteosarcoma cells with parthenolide |
Q36547077 | Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect |
Q40195204 | Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. |
Q33736691 | Targeting the tumor microenvironment |
Q37274132 | Targeting the tumor microenvironment: from understanding pathways to effective clinical trials |
Q30986775 | Telomere-mediated chromosomal instability triggers TLR4 induced inflammation and death in mice |
Q34961213 | Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer |
Q36141554 | Th1/Th2 Differentiation and B Cell Function by the Atypical PKCs and Their Regulators |
Q28275462 | The AP-1 repressor protein, JDP2, potentiates hepatocellular carcinoma in mice |
Q64388001 | The BRUCE-ATR Signaling Axis Is Required for Accurate DNA Replication and Suppression of Liver Cancer Development |
Q38162225 | The Chemokine CXCL8 in Carcinogenesis and Drug Response |
Q28593201 | The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20 |
Q37583280 | The Effects of Metformin on Obesity-Induced Dysfunctional Retinas |
Q36029051 | The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis |
Q37521523 | The Functional Haplotypes of CHRM3 Modulate mRNA Expression and Associate with Bladder Cancer among a Chinese Han Population in Kaohsiung City. |
Q36363512 | The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway |
Q35249092 | The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice |
Q37374645 | The IKK-related kinases: from innate immunity to oncogenesis |
Q28270208 | The IkappaB kinase - a bridge between inflammation and cancer |
Q89658487 | The Impact of IL-6 and IL-10 Gene Polymorphisms in Diffuse Large B-Cell Lymphoma Risk and Overall Survival in an Arab Population: A Case-Control Study |
Q99605605 | The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance |
Q40500532 | The Met protooncogene is a transcriptional target of NF kappaB: implications for cell survival |
Q96946162 | The MyD88 inhibitor TJ-M2010-2 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88/GSK-3β and MyD88/NF-κB signalling pathways |
Q36876973 | The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR. |
Q34596902 | The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy |
Q36386035 | The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease |
Q28390083 | The NIEHS Superfund Research Program: 25 Years of Translational Research for Public Health |
Q33717170 | The NOD-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer: a case-control study and gene expression analyses |
Q52597305 | The New Frontier: the Intestinal Microbiome and Surgery. |
Q28268422 | The Plasmodium circumsporozoite protein, a novel NF-κB inhibitor, suppresses the growth of SW480 |
Q35193883 | The Receptor for Advanced Glycation End-products (RAGE) protects pancreatic tumor cells against oxidative injury |
Q37108929 | The Rho-activating CNF1 toxin from pathogenic E. coli: a risk factor for human cancer development? |
Q38988591 | The Role of Indirubins in Inflammation and Associated Tumorigenesis. |
Q27486618 | The Role of Infectious Agents in the Etiology of Ocular Adnexal Neoplasia |
Q41500559 | The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer. |
Q26779929 | The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms |
Q28073691 | The Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with Inflammation |
Q39308380 | The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis |
Q38779629 | The Upregulation of TRAF1 Induced by Helicobacter pylori Plays an Antiapoptotic Effect on the Infected Cells |
Q38809044 | The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer |
Q28242458 | The activity of hsp90 alpha promoter is regulated by NF-kappa B transcription factors |
Q36990593 | The adaptive immune response to sporadic cancer |
Q37067708 | The anti-arthritic and immune-modulatory effects of NHAG: a novel glucosamine analogue in adjuvant-induced arthritis. |
Q35823298 | The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras. |
Q34128053 | The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis |
Q27026813 | The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms |
Q34547396 | The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role |
Q38115636 | The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders. |
Q41897354 | The biologic importance of tumor-infiltrating lymphocytes |
Q36666503 | The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development |
Q38129243 | The cytotoxic necrotizing factor 1 from E. coli: a janus toxin playing with cancer regulators. |
Q37115437 | The dark side of a tumor suppressor: anti-apoptotic p53. |
Q36835317 | The death domain-containing kinase RIP1 regulates p27(Kip1) levels through the PI3K-Akt-forkhead pathway |
Q92462353 | The diverse mechanisms and anticancer potential of naphthoquinones |
Q34392824 | The effect of sulindac, a non-steroidal anti-inflammatory drug, attenuates inflammation and fibrosis in a mouse model of chronic pancreatitis |
Q26748927 | The emerging role of FTY720 (Fingolimod) in cancer treatment |
Q35231687 | The functional role of reactive stroma in benign prostatic hyperplasia |
Q35513535 | The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver disease |
Q40141624 | The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation. |
Q35857513 | The human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha |
Q24318687 | The human homolog of the Drosophila headcase protein slows down cell division of head and neck cancer cells |
Q34287452 | The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFα |
Q37262995 | The immunological contribution of NF-κB within the tumor microenvironment: a potential protective role of zinc as an anti-tumor agent. |
Q38091503 | The impact of hypoxia on cell death pathways |
Q33997838 | The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers |
Q36508039 | The in vitro study of apoptosis in NB4 cell induced by citral |
Q93106964 | The indole compound MA-35 attenuates tumorigenesis in an inflammation-induced colon cancer model |
Q29616025 | The inflammasome NLRs in immunity, inflammation, and associated diseases |
Q37396607 | The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins |
Q37973270 | The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models |
Q54215473 | The inhibitory effect of a novel polypeptide fraction from Arca subcrenata on cancer-related inflammation in human cervical cancer HeLa cells. |
Q30248605 | The intestinal microbiome and surgical disease. |
Q51540350 | The joint association of REST and NFKB1 polymorphisms on the risk of colorectal cancer. |
Q38231122 | The molecular landscape of pediatric brain tumors in the next-generation sequencing era. |
Q47813995 | The nuclear factor-kappa B pathway and response to treatment in breast cancer |
Q26864149 | The pleiotropic effects of erythropoietin in infection and inflammation |
Q36959905 | The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma |
Q36945537 | The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease |
Q95650650 | The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges |
Q37212720 | The receptor RAGE: Bridging inflammation and cancer |
Q39865435 | The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma |
Q33685419 | The regulatory logic of the NF-kappaB signaling system |
Q38622386 | The role of chronic inflammation in the development of gastrointestinal cancers: reviewing cancer prevention with natural anti-inflammatory intervention |
Q34920381 | The role of cytokines in breast cancer development and progression |
Q33674221 | The role of dysregulated glucose metabolism in epithelial ovarian cancer |
Q38211081 | The role of inflammation in gastric cancer |
Q37834316 | The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases. |
Q38280869 | The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts |
Q39280466 | The role of tenascin-C in tissue injury and tumorigenesis |
Q42371680 | The role of toll-like receptor 4 in tumor microenvironment |
Q37400616 | The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism |
Q35530917 | The synergistic repressive effect of NF-κB and JNK inhibitor on the clonogenic capacity of Jurkat leukemia cells |
Q34264487 | The threonine protease activity of testes-specific protease 50 (TSP50) is essential for its function in cell proliferation |
Q36328530 | The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). |
Q34614516 | The transcription factor C/EBP-β mediates constitutive and LPS-inducible transcription of murine SerpinB2. |
Q36946019 | The tumor microenvironment and its role in promoting tumor growth |
Q37179521 | The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis |
Q53338021 | The tumour microenvironment as a target for chemoprevention. |
Q34947832 | The type III histone deacetylase Sirt1 protein suppresses p300-mediated histone H3 lysine 56 acetylation at Bclaf1 promoter to inhibit T cell activation |
Q24314649 | The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling |
Q39439223 | The unfolded protein response controls induction and activation of ADAM17/TACE by severe hypoxia and ER stress |
Q28509686 | The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation |
Q24300863 | Theileria-induced constitutive IKK activation is independent of functional Hsp90 |
Q92689597 | Therapeutic Effect of Y-27632 on Tumorigenesis and Cisplatin-Induced Peripheral Sensory Loss through RhoA-NF-κB |
Q42111707 | Therapeutic effect of a hydroxynaphthoquinone fraction on dextran sulfate sodium-induced ulcerative colitis |
Q38249091 | Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers |
Q37851151 | Therapeutic targeting of tumor-stroma interactions. |
Q47282821 | Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process |
Q34483693 | Thioredoxin-mediated negative autoregulation of peroxisome proliferator-activated receptor alpha transcriptional activity |
Q53359242 | Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer. |
Q38204742 | Toad glandular secretions and skin extractions as anti-inflammatory and anticancer agents |
Q30493047 | Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation |
Q92463719 | Tobacco, air pollution, environmental carcinogenesis, and thoughts on conquering strategies of lung cancer |
Q93080297 | Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods |
Q89509415 | Toll-like Receptors from the Perspective of Cancer Treatment |
Q37718417 | Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouracil by reducing its toxicity to normal tissues in mice |
Q37340298 | Toll-like receptors and cancer |
Q39023996 | Toll-like receptors and cutaneous melanoma |
Q37051007 | Toll-like receptors and immune regulation: implications for cancer therapy |
Q36898647 | Toll-like receptors in the brain and their potential roles in neuropathology. |
Q24289511 | Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples |
Q92618166 | Transcription coactivator p300 promotes inflammation by enhancing p65 subunit activation in type 2 diabetes nephropathy |
Q33762000 | Transcription factor co-repressors in cancer biology: roles and targeting |
Q44682175 | Transcriptional analysis of left-sided colitis, pancolitis, and ulcerative colitis-associated dysplasia |
Q33258202 | Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster |
Q33707936 | Transglutaminase regulation of cell function. |
Q90683678 | Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway |
Q33755300 | Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance |
Q34629999 | Trimodal color-fluorescence-polarization endoscopy aided by a tumor selective molecular probe accurately detects flat lesions in colitis-associated cancer |
Q34631363 | Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation |
Q36796876 | Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. |
Q38606460 | Tumor Microenvironment as a New Target for Tumor Immunotherapy of Polysaccharides |
Q35408783 | Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant |
Q33759698 | Tumor formation in a mouse model of colitis-associated colon cancer does not require COX-1 or COX-2 expression |
Q37762226 | Tumor immune therapy: lessons from infection and implications for cancer - can IL-7 help overcome immune inhibitory networks? |
Q36896195 | Tumor immunoediting and immunosculpting pathways to cancer progression. |
Q37832693 | Tumor microenvironment is multifaceted |
Q39675750 | Tumor necrosis factor receptor-associated factor-6 and ribosomal S6 kinase intracellular pathways link the angiotensin II AT1 receptor to the phosphorylation and activation of the IkappaB kinase complex in vascular smooth muscle cells |
Q41890825 | Tumor necrosis factor-α-induced a disintegrin and metalloprotease 10 increases apoptosis resistance in prostate cancer cells |
Q36997144 | Tumor stress, cell death and the ensuing immune response. |
Q39403895 | Tumor-Associated Macrophages as Target for Antitumor Therapy. |
Q37930487 | Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer |
Q37773280 | Tumor-associated macrophages as targets for tumor immunotherapy. |
Q39367300 | Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer |
Q38105286 | Tumor-associated macrophages: functional diversity, clinical significance, and open questions |
Q39087629 | Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression |
Q54998169 | Tumor-derived extracellular vesicles activate primary monocytes. |
Q37774865 | Tumor-initiating and -propagating cells: cells that we would like to identify and control |
Q92063581 | Tumor-neuroglia interaction promotes pancreatic cancer metastasis |
Q37085136 | Tumour immunity: effector response to tumour and role of the microenvironment |
Q58260579 | Tumour-associated macrophages secrete IL-6 and MCP-1 in head and neck squamous cell carcinoma tissue |
Q40283143 | Two distinct ubiquitin-dependent mechanisms are involved in NF-kappaB p105 proteolysis |
Q38616699 | Type I Interferon Supports Inducible Nitric Oxide Synthase in Murine Hepatoma Cells and Hepatocytes and during Experimental Acetaminophen-Induced Liver Damage |
Q39497268 | UDCA slows down intestinal cell proliferation by inducing high and sustained ERK phosphorylation |
Q36546697 | URGCP promotes non-small cell lung cancer invasiveness by activating the NF-κB-MMP-9 pathway. |
Q39345375 | USP2a negatively regulates IL-1β- and virus-induced NF-κB activation by deubiquitinating TRAF6. |
Q58759523 | USP4 positively regulates RLR-induced NF-κB activation by targeting TRAF6 for K48-linked deubiquitination and inhibits enterovirus 71 replication |
Q36601000 | Ubiquitin and ubiquitin-like proteins in cancer pathogenesis |
Q36996420 | Ubiquitin-like domain of IKKβ regulates osteoclastogenesis and osteolysis |
Q42056720 | Ubiquitylation of the initiator caspase DREDD is required for innate immune signalling. |
Q38336119 | Ultraviolet B radiation activates NF-κB and induces iNOS expression in HR-1 hairless mouse skin: role of IκB kinase-β. |
Q36989955 | Ultraviolet B regulation of transcription factor families: roles of nuclear factor-kappa B (NF-kappaB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis |
Q90726349 | Unmethylated CpG motif-containing genomic DNA fragment of Bacillus calmette-guerin promotes macrophage functions through TLR9-mediated activation of NF-κB and MAPKs signaling pathways |
Q28389159 | Unraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators? |
Q37765590 | Unravelling the complexity of cancer-immune system interplay |
Q84992338 | Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function |
Q34411599 | Upregulation of glucose metabolism by NF-κB2/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cells |
Q37645486 | Ursolic acid, a natural pentacyclic triterpenoid, inhibits intracellular trafficking of proteins and induces accumulation of intercellular adhesion molecule-1 linked to high-mannose-type glycans in the endoplasmic reticulum |
Q39409408 | Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages |
Q37712961 | Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma |
Q34774880 | Viral carcinogenesis: factors inducing DNA damage and virus integration |
Q37952350 | Viral interference with innate immunity by preventing NF-κB activity |
Q38137030 | Vitronectin--master controller or micromanager? |
Q88621887 | Walnut phenolic extract inhibits nuclear factor kappaB signaling in intestinal epithelial cells, and ameliorates experimental colitis and colitis-associated colon cancer in mice |
Q35847798 | Walterinnesia aegyptia venom combined with silica nanoparticles enhances the functioning of normal lymphocytes through PI3K/AKT, NFκB and ERK signaling. |
Q50666588 | What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori |
Q26827754 | When ubiquitin meets NF-κB: a trove for anti-cancer drug development |
Q24680891 | Why cancer and inflammation? |
Q26797301 | Why does obesity promote cancer? Epidemiology, biology, and open questions |
Q37376262 | Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway |
Q64949987 | Xanthatin inhibits STAT3 and NF-κB signalling by covalently binding to JAK and IKK kinases. |
Q49406138 | Xanthohumol prevents dextran sulfate sodium-induced colitis via inhibition of IKKβ/NF-κB signaling in mice |
Q46728352 | Z-ligustilide ameliorated ultraviolet B-induced oxidative stress and inflammatory cytokine production in human keratinocytes through upregulation of Nrf2/HO-1 and suppression of NF-κB pathway |
Q34462187 | Zinc deficiency activates S100A8 inflammation in the absence of COX-2 and promotes murine oral-esophageal tumor progression |
Q36262572 | alpha-Lipoic acid modulates extracellular matrix and angiogenesis gene expression in non-healing wounds treated with hyperbaric oxygen therapy |
Q89623393 | miR-125b and miR-223 Contribute to Inflammation by Targeting the Key Molecules of NFκB Pathway |
Q36193546 | miR-146a controls the resolution of T cell responses in mice |
Q89927111 | miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk |
Q60915354 | miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα |
Q37448131 | miR-221 promotes growth and invasion of hepatocellular carcinoma cells by constitutive activation of NFκB. |
Q55340090 | miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling. |
Q38847523 | miRNA in Macrophage Development and Function |
Q35086852 | miRNA regulation of cytokine genes |
Q38979891 | miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by regulating PKA and PP2A. |
Q50067509 | miR‑873 inhibits colorectal cancer cell proliferation by targeting TRAF5 and TAB1. |
Q86900164 | microRNA and NF-kappa B |
Q24647606 | p120-catenin mediates inflammatory responses in the skin |
Q28242189 | p21-activated kinases in cancer |
Q33303032 | p38 mitogen-activated protein kinase inhibition decreases TNFalpha secretion and protects against left ventricular remodeling in rats with myocardial ischemia |
Q37479790 | rpL3 promotes the apoptosis of p53 mutated lung cancer cells by down-regulating CBS and NFκB upon 5-FU treatment |
Q49235115 | α7 nicotinic acetylcholine receptor in tumor-associated macrophages inhibits colorectal cancer metastasis through the JAK2/STAT3 signaling pathway |
Q35151060 | β-Cryptoxanthin supplementation prevents cigarette smoke-induced lung inflammation, oxidative damage, and squamous metaplasia in ferrets |
Q64070916 | β-Hydroxy-β-methylbutyrate Suppresses NF-ĸB Activation and IL-6 Production in TE-1 Cancer Cells |
Search more.